
<!DOCTYPE html>
<html lang="en"     class="pb-page"  data-request-id="85f9c6aa-6d27-4ef5-b666-eb60a91cf21a"  
><head data-pb-dropzone="head"><meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="pbContext" content=";page:string:Article/Chapter View;ctype:string:Journal Content;website:website:pericles;article:article:doi\:10.1002/ijc.27989;issue:issue:doi\:10.1002/ijc.v133.1;journal:journal:10970215;wgroup:string:Publication Websites;pageGroup:string:Publication Pages;subPage:string:Full Text;requestedJournal:journal:10970215"/>

<script type="text/javascript">var $DoubleClickZone = "ij-cancer_ijc";var $DoubleClickSite =  "wly.onco.radthr_000091";</script><script id="analyticDigitalData">digitalData = {"site":{"ip":"216.165.249.165","environment":"LIVE","website":"onlinelibrary.wiley.com","websiteCode":"pericles","serverDate":"2022-03-06"},"identities":[{"type":"SmartGroupUser","uuid":"b238ab85-6bb4-49e4-84ca-a0d9f3ee5a35"},{"type":"SmartGroupUser","uuid":"eabce89b-65c2-4a09-ab7c-bd2b3fea2f10"},{"type":"RegionUser","uuid":"3c5060a1-6620-438f-862b-902a4d4cd4ac"},{"type":"BasicGroup","uuid":"e623deab-c83b-41e3-84a2-d9f1d46c5f17"},{"type":"SmartGroupUser","uuid":"a86d27d2-6bcd-4b94-bca5-fe16f4882855"},{"type":"InstitutionUser","uuid":"ea77208c-eba1-49cf-a446-5d73daccdfad","customerRecords":[{"customerDomain":"ALM-CU","customerNumber":"TESTOHIOSTATECOCHRANE"}]},{"type":"SmartGroupUser","uuid":"da88d808-3f7b-4bde-9210-10862b6d121b"},{"type":"SmartGroupUser","uuid":"8c72a733-117a-4bc9-a682-13475f13e6a3"},{"type":"SmartGroupUser","uuid":"756fc162-8722-461f-a077-ebffec4f4fae"},{"type":"SmartGroupUser","uuid":"cf9c85b9-7f3b-4309-aeaa-c41669cabe3b"},{"type":"SmartGroupUser","uuid":"db8b8d10-1aed-4809-b3ee-70938c569014"},{"type":"SmartGroupUser","uuid":"cdce41c2-a8de-4a64-a4d9-a85caaaa2314"},{"type":"SmartGroupUser","uuid":"39f911ce-44b6-4dba-9978-8b2e947a8eb0"},{"type":"RegionUser","uuid":"18971d33-e3f1-4194-be84-47668d10cf64"},{"type":"SmartGroupUser","uuid":"b7acda8c-ce18-451b-a68d-e14b72f9b5b8"},{"type":"SmartGroupUser","uuid":"055a2bdd-861f-4fa7-bd49-9773db7e0e3e"},{"type":"BasicGroup","uuid":"197fe835-5b5f-4f4e-b8e9-a74d68491a84"},{"type":"SmartGroupUser","uuid":"b2dbfe27-ecae-4bb6-bb0d-d75e5caa3762"},{"type":"SmartGroupUser","uuid":"1a6297fb-6679-4882-a4c2-fdd124624edf"},{"type":"SmartGroupUser","uuid":"8032f17e-5050-4fb4-9c40-e1f6875d5c2b"},{"type":"SmartGroupUser","uuid":"ab743440-628f-4964-9216-9983ad3beadf"},{"type":"SmartGroupUser","uuid":"a4187e00-f28e-4754-9a0f-1eb306fb0679"}],"publication":{"item":{"title":"The phosphatidylinositol‐3 kinase I inhibitor BKM120 induces cell death in B‐chronic lymphocytic leukemia cells \u003ci\u003ein vitro\u003c/i\u003e","doi":"10.1002/ijc.27989","access":"free","earliestDate":"2012-12-12","formats":["Abstract","Cited by","First page image","Full text","PDF","References","Supplementary Material"],"topics":[{"taxonomyUri":"global-subject-codes","topicLabel":"MEDICAL SCIENCE","topicUri":"md"},{"taxonomyUri":"global-subject-codes","topicLabel":"LIFE SCIENCES","topicUri":"ls"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pharmacology \u0026 Pharmaceutical Medicine","topicUri":"mdm0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Clinical Pharmacology \u0026 Therapeutics","topicUri":"mdm1"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pathology","topicUri":"mdk0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Oncology \u0026 Radiotherapy","topicUri":"mdh0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Surgical Oncology","topicUri":"mdh2"},{"taxonomyUri":"global-subject-codes","topicLabel":"Medical Oncology","topicUri":"mdh3"},{"taxonomyUri":"global-subject-codes","topicLabel":"Palliative Care","topicUri":"mdh4"},{"taxonomyUri":"global-subject-codes","topicLabel":"Hematology","topicUri":"mdc0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Cell \u0026 Molecular Biology","topicUri":"ls30"}]},"group":{"doi":"10.1002/ijc.v133.1","access":"free","volume":"133","issue":"1","coverDate":"2013-07-01","topics":[{"taxonomyUri":"global-subject-codes","topicLabel":"MEDICAL SCIENCE","topicUri":"md"},{"taxonomyUri":"global-subject-codes","topicLabel":"LIFE SCIENCES","topicUri":"ls"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pharmacology \u0026 Pharmaceutical Medicine","topicUri":"mdm0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Clinical Pharmacology \u0026 Therapeutics","topicUri":"mdm1"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pathology","topicUri":"mdk0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Oncology \u0026 Radiotherapy","topicUri":"mdh0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Surgical Oncology","topicUri":"mdh2"},{"taxonomyUri":"global-subject-codes","topicLabel":"Medical Oncology","topicUri":"mdh3"},{"taxonomyUri":"global-subject-codes","topicLabel":"Palliative Care","topicUri":"mdh4"},{"taxonomyUri":"global-subject-codes","topicLabel":"Hematology","topicUri":"mdc0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Cell \u0026 Molecular Biology","topicUri":"ls30"}]},"series":{"title":"International Journal of Cancer","doi":"10.1002/(ISSN)1097-0215","access":"no","code":"10970215","issn":"0020-7136","eissn":"1097-0215","topics":[{"taxonomyUri":"gpt-sitename","topicLabel":"wly.onco.radthr_000091","topicUri":"wly.onco.radthr_000091"},{"taxonomyUri":"global-subject-codes","topicLabel":"MEDICAL SCIENCE","topicUri":"md"},{"taxonomyUri":"global-subject-codes","topicLabel":"LIFE SCIENCES","topicUri":"ls"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pharmacology \u0026 Pharmaceutical Medicine","topicUri":"mdm0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Clinical Pharmacology \u0026 Therapeutics","topicUri":"mdm1"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pathology","topicUri":"mdk0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Oncology \u0026 Radiotherapy","topicUri":"mdh0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Surgical Oncology","topicUri":"mdh2"},{"taxonomyUri":"global-subject-codes","topicLabel":"Medical Oncology","topicUri":"mdh3"},{"taxonomyUri":"global-subject-codes","topicLabel":"Palliative Care","topicUri":"mdh4"},{"taxonomyUri":"global-subject-codes","topicLabel":"Hematology","topicUri":"mdc0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Cell \u0026 Molecular Biology","topicUri":"ls30"},{"taxonomyUri":"gpt-zonename","topicLabel":"ij-cancer_IJC","topicUri":"ij-cancer_ijc"}]}},"page":{"subPage":"Full Text","page":"Article/Chapter View","pageGroup":"Publication Pages","title":"title","errorCode":200},"tokens":{"tokenUsed":false}}</script>







<meta charset="UTF-8">




<meta name="robots" content="noarchive"/>





    














    






    <meta property="og:title" content="The phosphatidylinositol‐3 kinase I inhibitor BKM120 induces cell death in B‐chronic lymphocytic leukemia cells in vitro"/>


    <meta property="og:type" content="Article"/>


        <meta property="og:url" content="https://onlinelibrary.wiley.com/doi/10.1002/ijc.27989"/>
    

        
        <meta property="og:image" content="https://onlinelibrary.wiley.com/cms/asset/4688d0b2-95bb-45da-9cc0-240f6bae18b7/ijc.v133.1.cover.gif"/>
    

    <meta property="og:site_name" content="Wiley Online Library"/>



        

        <meta property="og:description" content="What's new? None of the standard treatments for chronic lymphocytic leukemia (CLL) result in curative therapy. In view of the critical role of PI3K in CLL homeostasis, here the authors examine the ac..."/>
    



    <meta name="viewport" content="width=device-width,initial-scale=1"/>






















    <link rel="preload" href="https://cmp.osano.com/AzZdRbSORDOOzF9W/67a788d8-9344-4c9b-a3c2-89b5073ee231/osano.js" as="script">
    <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/67a788d8-9344-4c9b-a3c2-89b5073ee231/osano.js"></script>




    

    <meta name="citation_doi" content="10.1002/ijc.27989"/>

    <meta name="dc.identifier" content="10.1002/ijc.27989"/>




<meta name="citation_journal_title" content="International Journal of Cancer"><meta name="citation_title" content="The phosphatidylinositol-3 kinase I inhibitor BKM120 induces cell death in B-chronic lymphocytic leukemia cells in vitro"><meta name="citation_keywords" content="chronic lymphocytic leukemia"><meta name="citation_keywords" content="BKM120"><meta name="citation_keywords" content="PI3K"><meta name="citation_keywords" content="leukemia therapy"><meta name="citation_keywords" content="CLL apoptosis"><meta name="citation_volume" content="133"><meta name="citation_issue" content="1"><meta name="citation_firstpage" content="247"><meta name="citation_lastpage" content="252"><meta name="citation_publication_date" content="2013/07/01"><meta name="citation_online_date" content="2013/01/15"><meta name="citation_issn" content="1097-0215"><meta name="citation_language" content="en"><meta name="citation_author" content="Lilian Amrein"><meta name="citation_author_institution" content="Department of OncologyFaculty of MedicineMcGill UniversityLady Davis Institute-Segal Cancer Center from the Jewish General HospitalMontrealQuebecCanada"><meta name="citation_author" content="May Shawi"><meta name="citation_author_institution" content="Department of OncologyFaculty of MedicineMcGill UniversityLady Davis Institute-Segal Cancer Center from the Jewish General HospitalMontrealQuebecCanada"><meta name="citation_author" content="Jeremy Grenier"><meta name="citation_author_institution" content="Department of OncologyFaculty of MedicineMcGill UniversityLady Davis Institute-Segal Cancer Center from the Jewish General HospitalMontrealQuebecCanada"><meta name="citation_author" content="Raquel Aloyz"><meta name="citation_author_institution" content="Department of OncologyFaculty of MedicineMcGill UniversityLady Davis Institute-Segal Cancer Center from the Jewish General HospitalMontrealQuebecCanada"><meta name="citation_author" content="Lawrence Panasci"><meta name="citation_author_institution" content="Department of OncologyFaculty of MedicineMcGill UniversityLady Davis Institute-Segal Cancer Center from the Jewish General HospitalMontrealQuebecCanada"><meta name="citation_abstract_html_url" content="https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.27989"><meta name="citation_fulltext_html_url" content="https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.27989"><meta name="citation_pdf_url" content="https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.27989"><meta name="citation_publisher" content="John Wiley & Sons, Ltd"><meta name="article_references" content="Amrein, L., Shawi, M., Grenier, J., Aloyz, R. and Panasci, L. (2013), The phosphatidylinositol-3 kinase I inhibitor BKM120 induces cell death in B-chronic lymphocytic leukemia cells in vitro. Int. J. Cancer, 133: 247-252. https://doi.org/10.1002/ijc.27989"><meta name="Description" content="BKM120, a pan class I PI3K inhibitor, was cytotoxic in the majority of primary B-chronic lymphocytic leukemia (CLL) lymphocytes, including samples from patients who have a high-risk for poor respon...">



<title>The phosphatidylinositol‐3 kinase I inhibitor BKM120 induces cell death in B‐chronic lymphocytic leukemia cells in vitro - Amrein - 2013 - International Journal of Cancer - Wiley Online Library</title>










<link rel="stylesheet" type="text/css" href="/wro/l0m7~product.css">

<link rel="preload" href="/products/acropolis/pericles/releasedAssets/fonts/icomoon/icomoon.woff?3a309d1f3a2b45cf678b" as="font" type="font/woff" crossorigin="anonymous"/><link rel="preload" href="/products/acropolis/pericles/releasedAssets/fonts/open-sans/open-sans-v15-latin-regular.woff2?3a309d1f3a2b45cf678b" as="font" type="font/woff2" crossorigin="anonymous"/><link rel="preload" href="/products/acropolis/pericles/releasedAssets/fonts/source-serif-pro/source-serif-pro-v5-latin-regular.woff2?3a309d1f3a2b45cf678b" as="font" type="font/woff2" crossorigin="anonymous"/><link rel="stylesheet" href="/products/acropolis/pericles/releasedAssets/css/build-3a309d1f3a2b45cf678b.css"/><link rel="stylesheet" href="/products/acropolis/pericles/releasedAssets/css/print-3a309d1f3a2b45cf678b.css" media="print"/>




<script async src="/pb-assets/catchpoint-1549680351760.js"></script>
<meta name="referrer" content="origin-when-cross-origin"/>
<link rel="shortcut icon" href="/favicon.ico">


<link rel="stylesheet" type="text/css" href="/pb-assets/hub-assets/pericles/hub-1645698573730.css">


<link rel="stylesheet" type="text/css" href="/pb-assets/css/iucr-1510734465460.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/css/readcube-1510565373110.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/css/dr-overrides-1611780866727.css">
<!-- link rel="stylesheet" type="text/css" href="/pb-assets/css/temporary-1525702334993.css" -->

<style>
/* PERICLES-7186: distorted cover images */
.journal-info-container .cover-image__image img {
    min-height: unset;
}

/* TEMPORARY CSS HACK TO FIX LIT-220590 */
.icon-icon-Rss::before {
    content: "\e629";
}

/* TEMPORARY CSS TO FIX ALIGNMENT OF TOP AD IN RIGHT RAIL */
.publication-cover-info {
    margin-bottom: 20px;
}

.article-row-right > .pb-ad {
    margin-left: 0;
    margin-bottom: 10px;
}

/* TEMPORARY HACK FOR PERICLES-6763 */
.table-of-content .issue-item h2 {
    font-size: 16px;
}

.table-of-content .issue-item h2 a.issue-item__title {
    display: inline;
}

/* TEMPORARY CSS FOR PERICLES-7445 */

input.saml__consent__yes {
    background: #005274;
    font-size: 12px;
    font-size: .75rem;
    padding: 12px 20px;
    border-radius: 0;
    margin-top: 20px;
    margin-right: 10px;
    width: 100px;
}

input.saml__consent__yes:hover {
    background: #003951;
}

/* PERICLES-2166: Site-wide maintenance message */

.admin-message {
    background-color: #005274;
    color: white;
}

/* TEMPORARY CSS FOR STAY-CONNECTED SOCIAL MEDIA ICONS */
.stay-connected ul  {
    list-style: none;
    margin: 0;
    padding: 0;
}

.stay-connected i {
    margin-right: 10px;
    font-size: 25px;
    line-height: 55px;
}

.stay-connected i.icon-hubs-rg-icon,
.stay-connected i.icon-hubs-soundcloud-icon {
    font-size: 41px;
}

.stay-connected .icon-hubs-pinterest-icon:before {
    color: white;
}

.stay-connected .icon-hubs-pinterest-icon {
    background-color: #BD081C;
    border: solid #BD081C;
    border-width: 8px;
}

/* PERICLES-5833: TEMPORARY CSS TO ADJUST POSITION OF ADS */
.article-mpu-bottom .pb-ad {
    margin: 0 0 0 195px;
}


.article-mpu-top .pb-ad {
    padding-top: 20px;
    margin: 0 0 -35px 0;
}

.banner-wrapper .pb-ad {
    padding: 0;
}

/* TEMPORARY CSS FOR THE SOCIETY MEMBER LOGIN PAGE */
.society-member-login .widget__header,
.society-member-login .show-registration,
.society-member-login .show-request-reset-password {
    display: none;
}

.society-member-login .login-form {
    margin-top: 20px;
}

.society-member-login .widget__body .input-group+.input-group {
    margin-top: 15px;
}


/* TEMPORARY CSS TO HIDE FPI IN TOP CONTENT ACTION WIDGET */
.top-content .firstPageImage {
	display: none;
}


.custom-page-pericles .main-content :target:before {
	content: "";
	display: block;
	height: 140px;
	margin: -140px 0 0;
}

/* PERICLES-4777: TEMPORARY CSS TO HIDE OPTIONS IN THE SIDEBAR ON MRW PAGES */
.journal-resources li#TableofContents,
.journal-resources li#Topics,
.journal-resources li#ArticleTitlesAZ {
	display: none;
}

/* TEMPORARY FIX FOR UNWANTED MARGIN BELOW COVER IMAGES ON BOOK SERIES PAGES */
.remove-margin .cover-image {
	margin: 0;
}

/* TEMPORARY FIX TO MAKE IT POSSIBLE TO EDIT RICH TEXT WIDGETS IN SLIDESHOWS */
.bs .modal-backdrop {
	display: none;
}

/* TEMPORARY FIX FOR MENU POSITION */
.hubpage-menu nav {
	padding-bottom: 0;
	position: relative;
}

/* TEMPORARY FOR MARGIN AROUND ADS */
.advert.advert-leaderboard {
	margin: 15px 0;
}

.banner-wrapper {
	box-shadow: none;
}

/* TEMPORARY TO FIX OVERFLOW FOR P IN JOURNAL-NEWS SLIDESHOWS */
.journal-news .slide-item p {
	overflow: unset;
}

/* EDITOR HIGHLIGHTS CSS */
div.ancillary-content.relateditem div.content {
	height: 10em;
}
div.ancillary-content.listitem div.content {
	height: 4em;
}

/* TEMPORARY Fix heading on Topical Index widget for MRWs */
.topical-index h2 {
    margin: 15px 0;
    font-size: 1.75rem;
    line-height: 28px;
    color: #1c1d1e;
    font-family: Source Serif Pro,serif;
    font-weight: normal;
}

/* PERICLES-7288 */
.issue-supplementary-files, .cover-image__virtual-issue {
    margin-bottom: 15px;
}

/* PERICLES-8875 */
.journal-news .slide-item img {
    float: left;
    margin-right: 10px;
}

/* DO NOT REMOVE */
li[heading="Restore Points"].ng-isolate-scope,
li[heading="Disable Widgets"].ng-isolate-scope {
    display: none!important;
}

.modal-header .widgetOrigin {
    display: none;
}

/* PERICLES-10090 */
.cover-image__image img {
    max-width: 150px;
    max-height: 150px;
}

/* LIT-282003 */
.journal-info-container span.info_value:after {
    content: '\003B';
}

.journal-info-container span.info_value:last-child:after {
    content: '';
}

/* LIT-299510 */
h1.citation__title {
    font-size: 22px;
    font-size: 1.375rem;
}

@media (max-width: 991px) {
    h1.citation__title {
        font-size: 18px;
        font-size: 1.125rem;
    }
    h1.citation__title:after {
        content: "";
    }
}

/* LIT-295816 */
.search__item .item__body .meta__details a.publication_meta_serial:after {
    content: "";
    margin: 0;
}
.search__item .item__body .meta__details a.publication_meta_volume_issue:before {
    content: "|";
    margin-left: 4px;
    margin-right: 4px;
}

/* PPV */
.cart-indicator__wrapper {
    padding: 0;
}

/* TrendMD Test */
#article__content #trendmd-suggestions{
    margin-top: 40px !important;
    border-top: 1px solid #ddd;

}
body #article__content .trendmd-widget-container {
    margin-top: 20px !important;
}

body #article__content .trendmd-widget-header__heading{
    font-size: 20px !important;
    margin-bottom: 30px !important
}
body #article__content .trendmd-widget-list-item__link, body #article__content .trendmd-widget-list-item__meta{
    font-family:'Open Sans', arial, sans-serif !important;
}
body #article__content .trendmd-widget{
	font-size:16px !important;
}
body #article__content .trendmd-widget-list-item{
	margin-bottom:24px !important;
}
body #article__content .trendmd-widget-list-item__link{
	color: #005293 !important;
}
body #article__content .trendmd-widget-list-item__meta{
	color: #5d5d5d !important;
	font-size:14px !important;
	margin-top:3px !important;
}
body #article__content .trendmd-widget_horizontal .trendmd-widget-section{
	width: 47% !important;
}

@media (max-width: 450px) {
	body #article__content .trendmd-widget_horizontal .trendmd-widget-section{
		width: 95% !important;
	}
}

#pane-pcw-related .trendmd-widget-header__heading{
	font-size: 18px !important;
	font-family:'Open Sans', arial, sans-serif !important;
}
#pane-pcw-related .trendmd-widget-container{
	padding:0 20px !important;
}
#pane-pcw-related .trendmd-widget-list-item__link{
	 font-family:'Open Sans', arial, sans-serif !important;
	 font-size:14px !important;
	 color: #005293 !important;
	 display:block;
	 margin-bottom: 5px !important;
}
#pane-pcw-related .trendmd-widget-list-item__meta{
	font-family:'Open Sans', arial, sans-serif !important;
	color:#666 !important;
}
#pane-pcw-related .trendmd-widget-list-item{
	margin-bottom:20px !important;
}


</style>

<!-- The Adobe DTM script. Must come after the digitalData object -->
<script src="//assets.adobedtm.com/6e626c9ec247e474f6b98eb15a79a185cf7e26a5/satelliteLib-c1ac050bbdc647f13a62578e71f0d817f8a6cbb5.js"></script>

<!-- Google Search Console verification -->
<meta name="google-site-verification" content="ffz4i4DxIJCdGpRXe0XN6KG6o4FYI-nnFW9I_dg8piM" />

<!-- KRUX Implementation-->
<script class="kxct" data-id="JMOONjNh" data-timing="async" data-version="1.9" type="text/javascript">

	window.Krux || (( Krux = function () {
		Krux.q.push ( arguments )
	}).q = []);

	( function () {
		var k , m , s , src;
		k = document.createElement ( 'script' );
		k.type 	= 'text/javascript';
		k.async = true;
		src = ( m = location.href.match ( /\bkxsrc=([^&]+)/ )) && decodeURIComponent ( m [ 1 ]);
		k.src = /^https?:\/\/([a-z0-9_\-\.]+\.)?krxd\.net(:\d{1,5})?\//i.test ( src ) ? src : src === 'disable' ? '' : ( location.protocol === 'https:'?'https:':'http:' ) + '//cdn.krxd.net/controltag?confid=JMOONjNh';
		s = document.getElementsByTagName ( 'script' ) [ 0 ];
		s.parentNode.insertBefore ( k , s );
	} ());
</script>

<!-- KRUX Implementation cont'd -->
<script type="text/javascript">
	window.Krux || (( Krux = function () {
		Krux.q.push ( arguments );
	}).q = []);

	( function () {
		function retrieve ( n ) {
			var m , k = 'kx' + n;
			if ( window.localStorage ) {
				return window.localStorage [ k ] || '';
			} else if ( navigator.cookieEnabled ) {
				m = document.cookie.match ( k + '=([^;]*)' );
				return ( m && unescape ( m [ 1 ])) || '';
			} else {
				return '';
			}
		}

		Krux.user = retrieve ( 'user' );
		Krux.segments = retrieve ( 'segs' ) && retrieve ( 'segs' ).split ( ',' ) || [];
	}) ();
</script>

<!-- Grapeshot Implementation -->
<script>
	var gs_channels = 'default';
</script>

<script src="//wiley.grapeshot.co.uk/main/channels.cgi?url=https://onlinelibrary.wiley.com/doi/10.1002/ijc.27989" async></script>

<!-- DoubleClick Implementation -->
<script type="text/javascript">
	var $WileyGooglePublisherID = 2215;

	if (!$DoubleClickSite) {
		switch("pericles") {
	  		case "acsess.onlinelibrary.wiley.com":
				var $DoubleClickSite = "wly.agriculture_000018";
				break;
			case "afspubs":
				var $DoubleClickSite = "wly.aqua.fish_000017";
				break;
			case "aasldpubs":
  				var $DoubleClickSite = "wly.gastro.hep_000059";
  				break;
			case "headachejournal":
  				var $DoubleClickSite = "wly.neurology_000086";
  				break;
  			case "wildlife":
				var $DoubleClickSite = "wly.zoology_000120";
				break;
			default:
				var $DoubleClickSite = "undefined-site";
		};
  	};

	if (!$DoubleClickZone) {
		switch("pericles") {
			case "acsess.onlinelibrary.wiley.com":
				var $DoubleClickZone = "Agriculture_ACSESS_Hub";
				break;
			case "afspubs":
				var $DoubleClickZone = "AFS_HUB";
				break;
			case "aasldpubs":
				var $DoubleClickZone = "AASLD-pubs_HUB";
				break;
			case "headachejournal":
				var $DoubleClickZone = "headache_HUB";
				break;
			case "wildlife":
				var $DoubleClickZone = "tws_HUB";
				break;
			default:
				var $DoubleClickZone = "undefined-zone";
		};
	};

	var $GooglePublisherCategory = "/" + $WileyGooglePublisherID + "/" + $DoubleClickSite + "/" + $DoubleClickZone;
</script>

<script>
	var googletag = googletag || {};

	googletag.cmd = googletag.cmd || [];

	( function () {

		var gads = document.createElement ( 'script' ) ,
		node = document.getElementsByTagName ( 'script' ) [ 0 ] ;

		gads.async = true;
		gads.src = document.location.protocol + '//www.googletagservices.com/tag/js/gpt.js';

		node.parentNode.insertBefore ( gads , node );

	}) ();
</script>

<script>
	googletag.cmd.push ( function () {

		var sizes = {
			leaderboard : googletag.sizeMapping ()
				.addSize ([ 300 , 100 ] , [ 300 , 50 ])
				.addSize ([ 740 , 100 ] , [ 728 , 90 ])
				.addSize ([ 0 , 0 ] , 'fluid')
				.build () ,
			rail : googletag.sizeMapping ()
				.addSize ([ 0 , 0 ] , [ 300 , 250 ])
				.build (),
			interstitial : googletag.sizeMapping ()
							.addSize ([ 0 , 0 ] , [ 640 , 480 ])
							.build ()

		};


		gptPage = window.digitalData && digitalData.page && digitalData.page.page ? digitalData.page.page : "blank";
		gptSubPage = window.digitalData && digitalData.page && digitalData.page.subPage ? digitalData.page.subPage : "blank";


		function gptClean(gptText){
			if(typeof(gptText)=="string"){
				gptText = gptText.replace(/\&/g,'%26');


				return gptText.replace(/\^|\*|#|\$|\"|\'|\=|\,|\!|\+|\~|\;|\(|\)|\<|\>|\[|\]|\?|\%|\:|\@|\;|\&|\||\{|\}|\\|/g,'');

			}
			return "blank";
		}


		googletag.pubads ()
			.setTargeting ( 'property' 	, 'value-of-property' 	) 	// Change and duplicate this line for as many additional keywords to send
			.setTargeting ( 'doi' , gptClean('10.1002/ijc.27989')) // Publication DOI
			.setTargeting ( 'gs_cat' 	, gs_channels 		) 	// Grapeshot
			.setTargeting ( 'ksg' 		, Krux.segments 	) 	// Krux
			.setTargeting ( 'kuid' 		, Krux.user 		) 	// Krux
			.setTargeting ( 'pbPage', gptClean(gptPage) )
			.setTargeting ( 'pbSubPage', gptClean(gptSubPage) )
			.setTargeting ( 'urlpath', gptClean(document.location.pathname));

		googletag.defineSlot ( $GooglePublisherCategory, 'fluid', 'advert-leaderboard' )
			.defineSizeMapping ( sizes.leaderboard )
			.addService ( googletag.pubads ())
			.setCollapseEmptyDiv ( true );

		googletag.defineSlot ( $GooglePublisherCategory, 'fluid', 'advert-rail-1' )
			.defineSizeMapping ( sizes.rail )
			.setTargeting ( 'Position', 'advert-rail-1')
			.addService ( googletag.pubads ())
			.setCollapseEmptyDiv ( true );

		googletag.defineSlot ( $GooglePublisherCategory, 'fluid', 'advert-rail-2' )
			.defineSizeMapping ( sizes.rail )
			.setTargeting ( 'Position', 'advert-rail-2')
			.addService ( googletag.pubads ())
			.setCollapseEmptyDiv ( true );

		googletag.defineSlot ( $GooglePublisherCategory, 'fluid', 'advert-video' )
			.defineSizeMapping ( sizes.interstitial )
			.setTargeting ( 'Position', 'advert-video')
			.addService ( googletag.pubads ())
			.setCollapseEmptyDiv ( true );


		googletag.pubads ().enableSingleRequest ();
		googletag.enableServices ();
	});
	//]]>
</script>

<script src="//validate.onecount.net/js/all.min.js#cff4b10c3a3d5cc9bbb7e2b9292cc66eae1deafa"></script>
<script>
	try {
		GCN.onecount.setTargeting();
	} catch (e) {
	}
</script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"65604cf31ed0e4d9","token":"f3dd54df2ac243bab2129483f57546d1","version":"2021.5.1","si":10}'></script>
<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"65cb04cf2c4898e7","token":"f3dd54df2ac243bab2129483f57546d1","version":"2021.5.2","si":10}'></script>
<script async src='/cdn-cgi/bm/cv/669835187/api.js'></script><script type="text/javascript">(function(){window['__CF$cv$params']={r:'65d1a8e0c92cd32a',m:'67aa9be47daef6356de6609e1160d5d3eaa5ffa2-1623318251-1800-AaebyrEA/0jUMhvUAOk0j/wUR0nsoq6UdvlB2Moolrehflza6iixm14P9MalQ+R8Vryip4agQZ71w0jrBJXqJEfdW+xLLufgGKZPRxJhvd4I3qMsuBop2ACJDvs+WtlCjNmSktt5c/WE8XBjCql0oD4=',s:[0x5aebccbc48,0x5cc5562061],}})();</script><script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"65d1a8e0c92cd32a","token":"f3dd54df2ac243bab2129483f57546d1","version":"2021.5.2","si":10}'></script>






    <!-- Get whether TNSI is in live or test mode -->
    
    <!-- Get the configured TNSI Javascript version number -->
    
    <!-- Get the configured TNSI MerchantID -->
    
    <!-- Add "TEST" to beginning of merchant ID when running in test mode -->
    

    










    
    

    
    
    
    
    <!-- loading Javascript for using the persistence Service -->
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        function getParameter(parameterName) {
            let result = null,
                tmp = [];
            location.search
                .substr(1)
                .split("&")
                .forEach(function (item) {
                    tmp = item.split("=");
                    if (tmp[0] === parameterName) result = tmp[1];
                });
            return result;
        }

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            queryParamsDelimiter: encodeURIComponent('?'),

            getWAYFLessUrl: function (entityId) {
                let redirectURL = getParameter('redirectUri');
                if(redirectURL == null){
                    redirectURL = encodeURIComponent(this.returnURL);
                }
                if(redirectURL.indexOf('saml_referrer') < 0){
                    redirectURL += encodeURIComponent(((redirectURL.indexOf(this.queryParamsDelimiter) !== -1) ? '&' : '?') + 'saml_referrer');
                }
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + redirectURL;
            },
            retrieveEntity: function () {
                var self = this;
                var ps = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve, reject) {
                    ps.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var ps = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    ps.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId, entityTitle) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId, entityTitle: entityTitle, eventGroupKey: '7adf2cc3-828c-4d79-bc97-f85204251f47'}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (let i in allSsoInstitutions) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID, ssoInstitution.entity.title)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>



    <script type="text/javascript">
        (function() {
            function riskifiedBeaconLoad() {
                var store_domain = 'https://onlinelibrary.wiley.com';
                var session_id = 'aaaX9G5-ds_aIaX1geD9x';
                var url = ('https:' == document.location.protocol ? 'https://' : 'http://')
                    + "beacon.riskified.com?shop=" + store_domain + "&sid=" + session_id;
                var s = document.createElement('script');
                s.type = 'text/javascript';
                s.async = true;
                s.src = url;
                var x = document.getElementsByTagName('script')[0];
                x.parentNode.insertBefore(s, x);
            }
            if (window.attachEvent)
                window.attachEvent('onload', riskifiedBeaconLoad)
            else
                window.addEventListener('load', riskifiedBeaconLoad, false);
        })();
    </script>


<script>
    var digitalData = window.digitalData ? window.digitalData : {};
    digitalData.page.title = "The phosphatidylinositol‐3 kinase I inhibitor BKM120 induces cell death in B‐chronic lymphocytic leukemia cells in vitro - Amrein - 2013 - International Journal of Cancer - Wiley Online Library";
</script><script async src='/cdn-cgi/bm/cv/669835187/api.js'></script></head>
<body class="pb-ui">

<div class="skip-links">
    <ul class="rlist">
        
                <li><a href="#article__content" tabindex="1">Skip to Article Content</a></li>
                <li><a href="#pane-pcw-detailscon" tabindex="1">Skip to Article Information</a></li>
            
    </ul>
</div>







    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="pageHeader" data-widget-id="62175478-b98a-43d5-90f2-1f2045ac1a7e" class="pageHeader">
        



        
        <header class="page-header">
    <div data-pb-dropzone="main">
    









        <div data-widget-def="ux3-layout-widget" data-widget-id="bb5b5e2c-d3d6-4015-b586-eeade38f59d4" class="admin-message">
        



        
        <div class="container"><div class="row"><div>



        
        



        <div class="pb-ad">
            <div style="background=blue;">
    <div class="container">
        <p style="text-align: center;"><b>Working off-campus?</b> Learn about our <a href="/action/clickThrough?id=101169&url=https%3A%2F%2Fonlinelibrary.wiley.com%2Fresearchers%2Fread%2Faccess-options&loc=%2Fdoi%2F10.1002%2Fijc.27989&pubId=50287102&placeholderId=1029&productId=1011" target="_blank" tabindex="2"><font color="white"><u>remote access options</u></font></a></p>
    </div>
</div>
        </div>
    

</div></div></div>

        </div>
    




        
        <div class="container"><div class="row"><div class="contents col-sm-12 col-md-12">



        
        <div class="pull-left">









        <div data-widget-def="ux3-general-image" data-widget-id="ff262197-0fb8-4973-aaa2-2fceba4b5a61" class="logo-container hidden-xs hidden-sm hidden-md">
        



        
        <a href="/" title="Wiley Online Library"><img id="mainLogo" alt="Wiley Online Library" src="/pb-assets/hub-assets/pericles/logo-header-1526603583437.png"/></a>

        </div>
    










        <div data-widget-def="ux3-general-image" data-widget-id="9a75b789-224c-4745-833a-930cf6c36f35" class="logo-container-mobile hidden-lg hidden-md hidden-sm">
        



        
        <a href="/" title="Wiley Online Library"><img id="mobileLogo" alt="Wiley Online Library" src="/pb-assets/hub-assets/pericles/mobilehublogo-1518781861020.png"/></a>

        </div>
    
</div><div class="pull-right">









        <div data-widget-def="UX3QuickSearchWidget" data-widget-id="48175bb0-0f70-46e6-bb89-7e2781fdb8e4" class="header-quicksearch">
        



        
        <div class="quick-search-wrapper"><a href="#" title="search" aria-label="Search" class="quick-search__item"><i aria-hidden="true" class="icon-search"></i><span class="quick-search__item__arrow"></span></a><div data-linkto-page="true" class="quick-search quickSearchFormContainer"><div class="main-search-field-wrapper"><div class="tab clearfix"><input type="search" placeholder="Search" value="" tabindex="13" class="fakeQSInput quickSearchFilter"/><label for="search-within" class="sr-only">Search within</label><select name="search-within" id="search-within" tabindex="10" class="search-within"><option value="#pane-67065c09-4a88-49cd-934c-ac707951d35c0" data-url="thisCategory" data-value="10970215">This Journal</option><option value="#pane-67065c09-4a88-49cd-934c-ac707951d35c1" data-url="https://onlinelibrary.wiley.com">Anywhere</option></select><ul role="tablist" class="rlist tab__content"><li id="pane-67065c09-4a88-49cd-934c-ac707951d35c0" aria-labelledby="pane-67065c09-4a88-49cd-934c-ac707951d35c0-con" role="tab" class="tab__pane quick-search-pane__anywhere active"><form action="/action/doSearch" name="thisJournalQuickSearch" method="get" title="Quick Search"><div class="input-group option-0"><label for="searchField0" class="hiddenLabel">Search term</label><input type="search" name="AllField" id="searchField0" placeholder="Search" onfocus="this.value = this.value;" data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" tabindex="9" class="autocomplete actualQSInput quickSearchFilter"/><input type="hidden" name="SeriesKey" value="10970215"/><div class="search-options-wrapper quickSearchFilter"><a href="https://onlinelibrary.wiley.com/search/advanced?publication=10970215" title="" tabindex="12" class="advanced">  Advanced Search</a><a href="https://onlinelibrary.wiley.com/search/advanced?publication=10970215#citation" title="" tabindex="12" class="citation">  Citation Search</a></div></div><button type="submit" title="Search" tabindex="11" aria-label="Submit Search" class="btn quick-search__button icon-search"></button></form></li><li id="pane-67065c09-4a88-49cd-934c-ac707951d35c1" aria-labelledby="pane-67065c09-4a88-49cd-934c-ac707951d35c1-con" role="tab" class="tab__pane quick-search-pane__anywhere"><form action="https://onlinelibrary.wiley.com/action/doSearch" name="defaultQuickSearch" method="get" title="Quick Search"><div class="input-group option-1"><label for="searchField1" class="hiddenLabel">Search term</label><input type="search" name="AllField" id="searchField1" placeholder="Search" onfocus="this.value = this.value;" data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" tabindex="9" class="autocomplete actualQSInput quickSearchFilter"/><div class="search-options-wrapper quickSearchFilter"><a href="https://onlinelibrary.wiley.com/search/advanced" title="" tabindex="12" class="advanced">  Advanced Search</a><a href="https://onlinelibrary.wiley.com/search/advanced#citation" title="" tabindex="12" class="citation">  Citation Search</a></div></div><button type="submit" title="Search" tabindex="11" aria-label="Submit Search" class="btn quick-search__button icon-search"></button></form></li></ul></div></div></div></div>

        </div>
    










        <div data-widget-def="ux3-layout-widget" data-widget-id="5ef13ed1-f4ac-4b62-a426-07ec9576a586" class="cart-indicator__wrapper">
        



        
        <div class="pull-left">









        <div data-widget-def="eCommerceCartIndicatorWidget" data-widget-id="4a9f7c04-a273-4a25-91fb-8e7bd9970288" class="cart-indicator__wrapper">
        



        
        















<div class="eCommerceCartIndicatorWidget">
    
            
        
</div>

        </div>
    
</div><div class="pull-right">









        <div data-widget-def="literatumNavigationLoginBar" data-widget-id="d384ca92-7137-45d6-b3c2-78c9c0a98c2b" class="login-bar-container">
        



        
        




    








        




    









    <div class="loginBar login-open">
        <a href="/action/showLogin?uri=%2Fdoi%2F10.1002%2Fijc.27989&amp;aria-label=Log+in+or+Register" class="show-login" role="button" uri="/doi/10.1002/ijc.27989" aria-label="Log in or Register">
            <span class="icon-profile_empty"></span>
            <span class="sign-in-label">Login / Register</span>
        </a>
            
    </div>


    


        </div>
    
</div>

        </div>
    
</div>
</div></div></div>
    </div>
</header>


        </div>
    










        <div data-widget-def="pageBody" data-widget-id="72100436-7a82-49fc-933b-c6c9d8c42914" class="pageBody article-page-tablet body-text">
        



        
        <main id="main-content" tabindex="-1">
    <!--begin pagefulltext-->
    <div class="page-body pagefulltext">
        <div data-pb-dropzone="main">
        



        
        <div>









        <div data-widget-def="literatumAd" data-widget-id="0220a30b-90c0-4b51-8637-141edf12f86a" class="banner-wrapper">
        



        
        



        <div class="pb-ad">
            <aside role="complementary">
		<div id="advert-leaderboard" class="advert advert-leaderboard">
			<script>
				googletag.cmd.push 		( function () {
					googletag.display 	( 'advert-leaderboard' );
				});
			</script>

			<!-- No JavaScript support is a call to an image -->
			<noscript>
				<a href="/action/clickThrough?id=1013&url=https%3A%2F%2Fpubads.g.doubleclick.net%2Fgampad%2Fjump%3Fiu%3D%24googlePublisherCategory%26amp%3Bsz%3D728x90%26amp%3Btile%3D1%26amp%3Bc%3D%24random&loc=%2Fdoi%2F10.1002%2Fijc.27989&pubId=50287102&placeholderId=1015&productId=101018" target="_blank">
					<img src="https://pubads.g.doubleclick.net/gampad/ad?iu=$googlePublisherCategory&amp;sz=728x90&amp;tile=1&amp;c=$random">
				</a>
			</noscript>
		</div>
	</aside>
        </div>
    


        </div>
    




        
        
</div>










        <section data-widget-def="ux3-layout-widget" data-widget-id="0f7bccba-8328-4dbd-a1fa-e84c526dd9ab">
        



        
        <div class="container"><div class="row"><div class=" col-md-12">



        
        <div>



        
        <article data-figures="/action/ajaxShowFigures?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1002%2Fijc.27989&amp;pbContext=%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27989%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v133.1%3Bjournal%3Ajournal%3A10970215%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215&amp;accordionHeadingWrapper=h2" data-references="/action/ajaxShowEnhancedAbstract?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1002%2Fijc.27989&amp;pbContext=%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27989%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v133.1%3Bjournal%3Ajournal%3A10970215%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215&amp;accordionHeadingWrapper=h2" data-related="/action/ajaxShowRecommended?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1002%2Fijc.27989&amp;pbContext=%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27989%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v133.1%3Bjournal%3Ajournal%3A10970215%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215&amp;accordionHeadingWrapper=h2&amp;showSubjects=true&amp;taxonomiesCodes=enter+your+taxonomy+codes+here&amp;displayCitedByLink=true&amp;displayAlmetricDropzone=true&amp;taxonomyUri=publication-features&amp;topicUri=hide-issue-metadata" data-details="/action/ajaxShowPubInfo?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1002%2Fijc.27989&amp;pbContext=%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27989%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v133.1%3Bjournal%3Ajournal%3A10970215%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215&amp;accordionHeadingWrapper=h2&amp;showSubjects=true&amp;taxonomiesCodes=enter+your+taxonomy+codes+here&amp;displayCitedByLink=true&amp;displayAlmetricDropzone=true&amp;taxonomyUri=publication-features&amp;topicUri=hide-issue-metadata" data-mathjax="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-AMS-MML_HTMLorMML"><div class="row article-row"><div id="article__content" tabindex="-1" class="col-sm-12 col-md-8 col-lg-8 article__content article-row-left"><div data-pb-dropzone="mrwBannerDropZone" class="mrw-banner-dropzone">



        
        
</div><div class="article-citation"><div class="citation">
   <div class="pb-dropzone" data-pb-dropzone="publicaitonContent-series-title"><div id="journal-banner-text" class="journal-banner-text"><a href="/journal/10970215" title="International Journal of Cancer homepage">International Journal of Cancer</a></div><a href="/toc/10970215/2013/133/1" class="volume-issue">Volume 133, Issue 1</a><span class="citation__page-range"> p. 247-252</span><a href="/journal/10970215" title="International Journal of Cancer homepage" class="citation--logo"><img id="journal-banner-image" test="test-value" alt="International Journal of Cancer" src="/pb-assets/journal-banners/10970215-1635434903757.jpg" class="journal-banner-image"></a><script>var image = new Image();

image.onerror = function() {
  // if the image does not exist
  //document.getElementById("journal-banner-text").style.marginBottom = "15px";
  document.getElementById("journal-banner-text").style.fontSize = "22px";
  document.getElementById("journal-banner-image").style.display = "none";
}

image.src = "/pb-assets/journal-banners/10970215-1635434903757.jpg";</script></div>
   <div class="doi-access-container clearfix"><span class="primary-heading"><span class="primary-heading">Short Report</span></span><div class="doi-access-wrapper"><div class="free-access access-type"><i aria-hidden="true" class="icon-icon-lock_open"></i><div class="doi-access">Free Access</div></div></div></div>
   <h1 class="citation__title">The phosphatidylinositol-3 kinase I inhibitor BKM120 induces cell death in B-chronic lymphocytic leukemia cells <i>in vitro</i></h1>
   <div class="accordion corrections-container">
      <h2 class="corrections-title"><a id="single-accordion-controller-idd11855693" href="#" title="Single Accordion Controller" class="accordion__control corrections-label w-slide__btn" data-slide-target="#d11855693" aria-expanded="false" role="button"><i aria-hidden="true" class="info-icon icon-notice"></i><span class="corrections-label__text">Correction(s) for this article</span><i aria-hidden="true" class="icon-arrow icon-keyboard_arrow_down"></i></a></h2>
      <div style="display: none;" id="d11855693" class="accordion__content corrections-body hidden-xs hidden-sm" role="region" aria-labelledby="single-accordion-controller-idd11855693">
         <ul class="rlist separator corrections-container__list">
            <li><a href="/doi/10.1002/ijc.29554">
   <h6>Erratum</h6></a><div class="parent-item">
   <ul class="rlist--inline separator">
      <li><span class="comma">Volume 137</span><span class="comma">Issue 8</span><span>International Journal of Cancer</span></li>
      <li><span>pages: E15-E15</span></li>
      <li>First Published online: August 7, 2015</li>
   </ul>
</div></li>
         </ul>
      </div>
   </div>
   <div class="loa comma visible-xs mobile-authors loa-authors-trunc">
      <div class="comma__list"><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Amrein%2C+Lilian" class="author-name accordion-tabbed__control" data-id="am1" data-db-target-for="am1" aria-controls="am1" aria-haspopup="true" id="am1_Ctrl" role="button"><span>Lilian Amrein</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am1" aria-labelledby="am1_Ctrl" role="region" id="am1">
               <p class="author-name">Lilian Amrein</p>
               <p>Department of Oncology, Faculty of Medicine, McGill University, Lady Davis Institute-Segal Cancer Center from the Jewish General Hospital, Montreal, Quebec, Canada</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Amrein%2C+Lilian">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Shawi%2C+May" class="author-name accordion-tabbed__control" data-id="am2" data-db-target-for="am2" aria-controls="am2" aria-haspopup="true" id="am2_Ctrl" role="button"><span>May Shawi</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am2" aria-labelledby="am2_Ctrl" role="region" id="am2">
               <p class="author-name">May Shawi</p>
               <p>Department of Oncology, Faculty of Medicine, McGill University, Lady Davis Institute-Segal Cancer Center from the Jewish General Hospital, Montreal, Quebec, Canada</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Shawi%2C+May">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Grenier%2C+Jeremy" class="author-name accordion-tabbed__control" data-id="am3" data-db-target-for="am3" aria-controls="am3" aria-haspopup="true" id="am3_Ctrl" role="button"><span>Jeremy Grenier</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am3" aria-labelledby="am3_Ctrl" role="region" id="am3">
               <p class="author-name">Jeremy Grenier</p>
               <p>Department of Oncology, Faculty of Medicine, McGill University, Lady Davis Institute-Segal Cancer Center from the Jewish General Hospital, Montreal, Quebec, Canada</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Grenier%2C+Jeremy">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Aloyz%2C+Raquel" class="author-name accordion-tabbed__control" data-id="am4" data-db-target-for="am4" aria-controls="am4" aria-haspopup="true" id="am4_Ctrl" role="button"><span>Raquel Aloyz<i aria-hidden="true" class="icon-mail_outline"></i></span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am4" aria-labelledby="am4_Ctrl" role="region" id="am4">
               <p class="author-type mb-1">Corresponding Author</p>
               <p class="author-name">Raquel Aloyz</p>
               <p>Department of Oncology, Faculty of Medicine, McGill University, Lady Davis Institute-Segal Cancer Center from the Jewish General Hospital, Montreal, Quebec, Canada</p>Correspondence to: Lawrence Panasci or Raquel Aloyz, 3755 Cote Ste Catherine Road, H3T 1E2, Montreal, Quebec, Canada, Tel.: +514-3408248, Fax: +514-3408302, E-mail: <a class="corr-email" title="Link to email address" href="mailto:lpanasci@hotmail.com"><span>lpanasci@hotmail.com</span></a> or <a class="corr-email" title="Link to email address" href="mailto:raquel.aloyz@mcgill.ca"><span>raquel.aloyz@mcgill.ca</span></a><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Aloyz%2C+Raquel">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Panasci%2C+Lawrence" class="author-name accordion-tabbed__control" data-id="am5" data-db-target-for="am5" aria-controls="am5" aria-haspopup="true" id="am5_Ctrl" role="button"><span>Lawrence Panasci<i aria-hidden="true" class="icon-mail_outline"></i></span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am5" aria-labelledby="am5_Ctrl" role="region" id="am5">
               <p class="author-type mb-1">Corresponding Author</p>
               <p class="author-name">Lawrence Panasci</p>
               <p>Department of Oncology, Faculty of Medicine, McGill University, Lady Davis Institute-Segal Cancer Center from the Jewish General Hospital, Montreal, Quebec, Canada</p>Correspondence to: Lawrence Panasci or Raquel Aloyz, 3755 Cote Ste Catherine Road, H3T 1E2, Montreal, Quebec, Canada, Tel.: +514-3408248, Fax: +514-3408302, E-mail: <a class="corr-email" title="Link to email address" href="mailto:lpanasci@hotmail.com"><span>lpanasci@hotmail.com</span></a> or <a class="corr-email" title="Link to email address" href="mailto:raquel.aloyz@mcgill.ca"><span>raquel.aloyz@mcgill.ca</span></a><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Panasci%2C+Lawrence">Search for more papers by this author</a></div></span></div>
   </div>
   <div class="loa-wrapper loa-authors hidden-xs desktop-authors">
      <div id="sb-1" class="accordion">
         <div class="comma__list">
            <div class="accordion-tabbed"><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Amrein%2C+Lilian" class="author-name accordion-tabbed__control" data-id="a1" data-db-target-for="a1" aria-controls="a1" aria-haspopup="true" id="a1_Ctrl" role="button"><span>Lilian Amrein</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a1" aria-labelledby="a1_Ctrl" role="region" id="a1">
                     <p class="author-name">Lilian Amrein</p>
                     <p>Department of Oncology, Faculty of Medicine, McGill University, Lady Davis Institute-Segal Cancer Center from the Jewish General Hospital, Montreal, Quebec, Canada</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Amrein%2C+Lilian">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Shawi%2C+May" class="author-name accordion-tabbed__control" data-id="a2" data-db-target-for="a2" aria-controls="a2" aria-haspopup="true" id="a2_Ctrl" role="button"><span>May Shawi</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a2" aria-labelledby="a2_Ctrl" role="region" id="a2">
                     <p class="author-name">May Shawi</p>
                     <p>Department of Oncology, Faculty of Medicine, McGill University, Lady Davis Institute-Segal Cancer Center from the Jewish General Hospital, Montreal, Quebec, Canada</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Shawi%2C+May">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Grenier%2C+Jeremy" class="author-name accordion-tabbed__control" data-id="a3" data-db-target-for="a3" aria-controls="a3" aria-haspopup="true" id="a3_Ctrl" role="button"><span>Jeremy Grenier</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a3" aria-labelledby="a3_Ctrl" role="region" id="a3">
                     <p class="author-name">Jeremy Grenier</p>
                     <p>Department of Oncology, Faculty of Medicine, McGill University, Lady Davis Institute-Segal Cancer Center from the Jewish General Hospital, Montreal, Quebec, Canada</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Grenier%2C+Jeremy">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Aloyz%2C+Raquel" class="author-name accordion-tabbed__control" data-id="a4" data-db-target-for="a4" aria-controls="a4" aria-haspopup="true" id="a4_Ctrl" role="button"><span>Raquel Aloyz<i aria-hidden="true" class="icon-mail_outline"></i></span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a4" aria-labelledby="a4_Ctrl" role="region" id="a4">
                     <p class="author-type mb-1">Corresponding Author</p>
                     <p class="author-name">Raquel Aloyz</p>
                     <p>Department of Oncology, Faculty of Medicine, McGill University, Lady Davis Institute-Segal Cancer Center from the Jewish General Hospital, Montreal, Quebec, Canada</p>Correspondence to: Lawrence Panasci or Raquel Aloyz, 3755 Cote Ste Catherine Road, H3T 1E2, Montreal, Quebec, Canada, Tel.: +514-3408248, Fax: +514-3408302, E-mail: <a class="corr-email" title="Link to email address" href="mailto:lpanasci@hotmail.com"><span>lpanasci@hotmail.com</span></a> or <a class="corr-email" title="Link to email address" href="mailto:raquel.aloyz@mcgill.ca"><span>raquel.aloyz@mcgill.ca</span></a><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Aloyz%2C+Raquel">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Panasci%2C+Lawrence" class="author-name accordion-tabbed__control" data-id="a5" data-db-target-for="a5" aria-controls="a5" aria-haspopup="true" id="a5_Ctrl" role="button"><span>Lawrence Panasci<i aria-hidden="true" class="icon-mail_outline"></i></span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a5" aria-labelledby="a5_Ctrl" role="region" id="a5">
                     <p class="author-type mb-1">Corresponding Author</p>
                     <p class="author-name">Lawrence Panasci</p>
                     <p>Department of Oncology, Faculty of Medicine, McGill University, Lady Davis Institute-Segal Cancer Center from the Jewish General Hospital, Montreal, Quebec, Canada</p>Correspondence to: Lawrence Panasci or Raquel Aloyz, 3755 Cote Ste Catherine Road, H3T 1E2, Montreal, Quebec, Canada, Tel.: +514-3408248, Fax: +514-3408302, E-mail: <a class="corr-email" title="Link to email address" href="mailto:lpanasci@hotmail.com"><span>lpanasci@hotmail.com</span></a> or <a class="corr-email" title="Link to email address" href="mailto:raquel.aloyz@mcgill.ca"><span>raquel.aloyz@mcgill.ca</span></a><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Panasci%2C+Lawrence">Search for more papers by this author</a></div></span></div>
         </div>
      </div>
   </div>
   <div class="epub-sections"><div class="epub-section"><span class="epub-state">First published: </span><span class="epub-date">12 December 2012</span></div>
      <div class="epub-section"><a class="epub-doi" aria-label="Digital Object Identifier" href="https://doi.org/10.1002/ijc.27989">https://doi.org/10.1002/ijc.27989</a></div><div class="epub-section cited-by-count"><span>Citations: <a href="#citedby-section">31</a></span></div></div></div></div><div class="fixedCoolBar"><nav aria-label="Article navigation and tools" class="coolBar stickybar"><div class="stickybar__wrapper coolBar__wrapper clearfix"><div class="rlist coolBar__zone"><div class="coolBar__section"><a href="javascript:void(0)" data-db-target-for="article" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="article_Pop" role="button" id="article_Ctrl" class="coolBar__ctrl hidden-lg"><i class="icon-abstract"></i><span>About</span></a><div data-db-target-of="article" aria-labelledby="article_Ctrl" role="menu" id="article_Pop" class="coolBar__drop fixed rlist dropBlock__holder"><div data-target=".article-row-right .tab__nav, .coolBar--download" data-remove="false" data-targetClass="hidden-xs hidden-sm" data-toggle="transplant" data-direction="from" data-transplant="self" class="transplant showit"></div></div></div><div class="coolBar__section coolBar--sections"><a id="sections_Ctrl" href="javascript:void(0)" data-db-target-for="sections" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="sections_Pop" role="button" class="coolBar__ctrl"><i class="icon-list-unordered"></i><span>Sections</span></a><div data-db-target-of="sections" aria-labelledby="sections_Ctrl" role="menu" id="sections_Pop" class="coolBar__drop dropBlock__holder rlist fixed"></div></div></div><div class="coolBar__second rlist"><div class="coolBar__section coolBar--download PdfLink"><a href="/doi/epdf/10.1002/ijc.27989" title="ePDF" class="coolBar__ctrl pdf-download"><img src="/products/pericles/releasedAssets/images/pdf-icon.png" alt="PDF"/>PDF</a></div>



        
        <div class="relative"><a href="#" data-db-target-for="0e406ce9-5c43-4e2d-b741-e0b43d1f1865" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Pop" role="button" id="0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Ctrl" class="article-tools__ctrl"><i aria-hidden="true" class="icon-Icon_Tools"></i><span>Tools</span></a><div data-db-target-of="0e406ce9-5c43-4e2d-b741-e0b43d1f1865" aria-labelledby="0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Ctrl" role="menu" id="0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Pop" class="article-tools__block fixed dropBlock__holder"><ul class="rlist w-slide--list"><li role="presentation" class="article-tool"><a href="https://onlinelibrary.wiley.com/action/rightsLink?doi=10.1002%2Fijc.27989&amp;mode=" role="menuitem" target="_blank"><i aria-hidden="true" class="icon-permissions-key"></i><span>Request permission</span></a></li><li role="presentation" class="article-tool"><a href="/action/showCitFormats?doi=10.1002%2Fijc.27989" role="menuitem" target="_self"><i aria-hidden="true" class="icon-export-icon"></i><span>Export citation</span></a></li><li role="presentation" class="article-tool"><a href="/personalize/addFavoritePublication?doi=10.1002%2Fijc.27989" role="menuitem" target="_self"><i aria-hidden="true" class="icon-favorites"></i><span>Add to favorites</span></a></li><li role="presentation" class="article-tool"><a href="/action/addCitationAlert?doi=10.1002%2Fijc.27989" role="menuitem" target="_self"><i aria-hidden="true" class="icon-Icon_Track-citations"></i><span>Track citation</span></a></li></ul></div></div>




        
        <!-- Go to www.addthis.com/dashboard to customize your tools --><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-51225be51b56b4c4"></script><div class="relative"><a id="share-access__ctrl" href="#" data-db-target-for="dff42abe-4b17-4fe9-a9c5-625405cd1007" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="share_Pop" role="button" class="share-access__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i><span>Share</span></a><a id="share__ctrl" href="#" data-db-target-for="dff42abe-4b17-4fe9-a9c5-625405cd1007" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="share_Pop" role="button" class="share__ctrl hidden"><i aria-hidden="true" class="icon-Icon_Share"></i><span>Share</span></a><div data-db-target-of="dff42abe-4b17-4fe9-a9c5-625405cd1007" aria-labelledby="share-access__ctrl" role="menu" id="share_Pop" class="share__block dropBlock__holder fixed">



        
        <div data-share-access="/action/authorizeSharing?doi=10.1002/ijc.27989&amp;shareType=P2P" class="share-access hidden"><p>Give access</p><a href="#" data-toggle="modal" data-target="#shareAccess" class="share-access__link"><i class="icon-users"></i>Share full text access</a></div><div class="ux-modal-container share-access__modal"><div id="shareAccess" class="modal"><div class="modal__dialog"><div class="modal__header"><button type="button" data-dismiss="modal" class="close"><i aria-hidden="true" class="icon-close_thin"></i></button><p>Share full-text access</p></div><div class="modal__body"><form method="post"><fieldset><legend>Please review our <a href="https://onlinelibrary.wiley.com/termsAndConditions" target="_blank">Terms and Conditions of Use</a> and check box below to share full-text version of article.</legend><div class="input-group"><label for="terms-and-conditions" class="checkbox--primary"><input id="terms-and-conditions" type="checkbox" value="yes" required="" name="terms-and-conditions" data-ajax-link="/action/generateShareUrl?doi=10.1002/ijc.27989&amp;shareType=P2P&amp;format=FULL-TEXT" data-shareable-link=""/><span class="label-txt">I have read and accept the Wiley Online Library Terms and Conditions of Use</span></label></div></fieldset><hr class="separator"/><div class="shareable"><label>Shareable Link</label><p>Use the link below to share a full-text version of this article with your friends and colleagues. <a href="https://onlinelibrary.wiley.com/researchers/tools-resources/sharing" target="_blank" class="emphasis">Learn more.</a></p><div class="shareable__box"><div class="shareable__text"><div class="shareable__field"><span id="shareable__text"></span><textarea tabindex="-1" class="shareable__text-area"></textarea></div></div><button type="submit" disabled="" class="btn shareable__btn">Copy URL</button></div><div class="error shareable__error hidden"></div></div></form></div></div></div></div>
<p>Share a link</p><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter-t"></i>Twitter</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit-alien"></i>Reddit</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li></ul></div></div>
</div></div></nav></div><div id="accessDenialslot" class="accessDenialslot"></div><div class="article__body "><article>
   
   <section class="article-section article-section__abstract" lang="en" data-lang="en" id="section-1-en">
      <h2 id="d11856968" class="article-section__header section__title main main">Abstract</h2>
      <div class="article-section__content en main">
         <p>BKM120, a pan class I PI3K inhibitor, was cytotoxic in the majority of primary B-chronic lymphocytic leukemia (CLL) lymphocytes, including samples from patients who have a high-risk for poor response to treatment (patient with del11 and del17) at clinically obtainable concentrations. The PI3Kδ inhibitor Cal-101 is cytotoxic in B-CLL lymphocytes <i>in vitro</i> and is active in the treatment of CLL <i>in vivo</i>. Interestingly, we demonstrated that BKM120 is 3.6 fold more toxic than Cal-101 in malignant B-CLL lymphocytes <i>in vitro</i>. BKM120 cytotoxicity correlated with the basal expression of proteins involved in the PI3K/Akt pathway. A protein signature of PI3K pathway proteins predicts the response to BKM120 treatment. In the primary B-CLL lymphocytes tested <i>in vitro</i>, BKM120 decreased the phosphorylation status of molecular biomarkers used as indicators of PI3K pathway inhibition <i>in vivo</i>. Also, BKM120 induced apoptosis in primary B-CLL cells culture in the presence and absence of stromal cell support. Our findings suggest that BKM120 should be tested clinically in CLL.</p>
         </div>
   </section>
   <section class="article-section article-section__abstract" lang="en" data-lang="en" id="section-1-en">
      <h2 id="d11856986" class="article-section__header short short">Abstract</h2>
      <div class="article-section__content en short">
         <p><b>What's new?</b></p>
         <p>None of the standard treatments for chronic lymphocytic leukemia (CLL) result in curative therapy. In view of the critical role of PI3K in CLL homeostasis, here the authors examine the activity of the pan class I PI3K inhibitor BKM120. They find that clinically achievable concentrations of BKM120 have antitumor activity in CLL lymphocytes associated with down-regulation of the PI3K pathway <i>in vitro</i>. They identify a protein signature predicting BKM120 sensitivity in CLL lymphocytes. Moreover, BKM120 presents significantly greater cytotoxicity than the PI3Kδ inhibitor Cal-101, which is especially relevant since Cal-101 has known antitumor activity in relapsed CLL patients.</p>
         </div>
   </section>
   <div class="pb-dropzone" data-pb-dropzone="below-abstract-group"><!-- Empty dropzone --></div>
   
   <section class="article-section article-section__full">
      <h3 class="list-paired__title">Abbreviations</h3>
      <div class="list-paired" id="ijc27989-lp-0001">
         <dl>
            <dt>
               <li>BCR</li>
            </dt>
            <dd>
               <li>B-cell receptor</li>
            </dd>
            <dt>
               <li>BTK</li>
            </dt>
            <dd>
               <li>Bruton tyrosine kinase</li>
            </dd>
            <dt>
               <li>CLL</li>
            </dt>
            <dd>
               <li>chronic lymphocytic leukemia</li>
            </dd>
            <dt>
               <li>DMEM</li>
            </dt>
            <dd>
               <li>Dulbecco's modified eagle medium</li>
            </dd>
            <dt>
               <li>FBS</li>
            </dt>
            <dd>
               <li>fetal bovine serum</li>
            </dd>
            <dt>
               <li>FCR</li>
            </dt>
            <dd>
               <li>fludarabine, cyclophosphamide and rituximab</li>
            </dd>
            <dt>
               <li>MRD</li>
            </dt>
            <dd>
               <li>minimal residual disease</li>
            </dd>
            <dt>
               <li>PI</li>
            </dt>
            <dd>
               <li>phosphoinositide</li>
            </dd>
         </dl>
      </div>
      <section class="article-section__content" id="ijc27989-sec-0001">
         
         <p>Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of malignant B lymphocytes expressing the surface antigens CD19, CD20, CD23 and CD5.<span><a href="#ijc27989-bib-0001" class="bibLink tab-link" id="ijc27989-bib-0001R" data-tab="pane-pcw-references" aria-label="Reference 1 - J Exp Med">1</a></span> These B-CLL cells display altered apoptosis that is caused by both primary tumor features and co-dependent stromal elements.<span><a href="#ijc27989-bib-0002" class="bibLink tab-link" id="ijc27989-bib-0002R" data-tab="pane-pcw-references" aria-label="Reference 2 - Blood">2</a></span> Current treatments for this disease include chemotherapeutic [alkylating agents (chlorambucil, cyclophosphamide, bendamustine)], purine analogs (Fludarabine) and immunotherapeutic agents (Rituximab, Alemtuzumab) or the combination of immunotherapy with chemotherapeutics drugs [the gold standard for CLL treatment is now fludarabine, cyclophosphamide and rituximab (FCR)]. However, none of these standard treatments result in curative therapy supporting the need for the investigation of new therapeutic targets and drug development in CLL as well as markers that can predict the clinical response to these treatments.<span><a href="#ijc27989-bib-0003" class="bibLink tab-link" id="ijc27989-bib-0003R" data-tab="pane-pcw-references" aria-label="Reference 3 - J Clin Oncol">3</a></span></p>
         
         <p>The B-cell receptor (BCR) signaling has been considered critical for B-CLL survival and recent studies demonstrated that inhibition of the Bruton tyrosine kinase (BTK), a BCR associated kinase, blocked chemokines signaling leading to inhibition of CLL cell migration and survival resulting in CLL regression.<span><a href="#ijc27989-bib-0004" class="bibLink tab-link" id="ijc27989-bib-0004R" data-tab="pane-pcw-references" aria-label="Reference 4 - Blood">4</a>, <a href="#ijc27989-bib-0005" class="bibLink tab-link" id="ijc27989-bib-0005R" data-tab="pane-pcw-references" aria-label="Reference 5 - Blood">5</a></span></p>
         
         <p>The phosphoinositide 3-kinase (PI3K) cascade is also a critical component of survival signaling including PI3K-activated Akt (phosphorylated Akt) which inhibits cell death pathways by inactivating pro-apoptotic proteins such as Bad, procaspase-9 and members of the Forkhead transcription factor family. Overexpression of PI3K appears to play a critical role in B-CLL cell survival. Freshly isolated CLL lymphocytes have high levels of NF-κB activity and loss of NF-κB and Akt activity is associated with apoptosis.<span><a href="#ijc27989-bib-0006" class="bibLink tab-link" id="ijc27989-bib-0006R" data-tab="pane-pcw-references" aria-label="Reference 6 - Blood">6</a>-<a href="#ijc27989-bib-0008" class="bibLink tab-link" id="ijc27989-bib-0008R" data-tab="pane-pcw-references" aria-label="Reference 8 - Blood">8</a></span> Cal-101 is a specific inhibitor of the delta isoform of phosphatidylinositol-3-kinase; the delta isoform is expressed primarily in hematopoietic lineages and is functionally important in B cells. Preclinical data suggest that Cal-101 is cytotoxic to CLL <i>in vitro</i>.<span><a href="#ijc27989-bib-0008" class="bibLink tab-link" id="ijc27989-bib-0008R" data-tab="pane-pcw-references" aria-label="Reference 8 - Blood">8</a></span> At the 2010 ASH meeting, results were presented of a phase I study of 37 patients with CLL who were treated with Cal-101.<span><a href="#ijc27989-bib-0009" class="bibLink tab-link" id="ijc27989-bib-0009R" data-tab="pane-pcw-references" aria-label="Reference 9 - ASH Annual Meeting Abstracts">9</a></span> Patients had a median of five prior regimens; 65% were refractory to their most recent prior regimen; 81% had bulky lymphadenopathy; and 36% of the patients had del17. All patients showed reduction in lymphadenopathy with 80% achieving a nodal response. However, concomitant with the decrease in lymphadenopathy there was an increase in lymphocytosis in about 60% of patients over the first 1–2 months of therapy. This lymphocytosis appeared to represent a redistribution of lymphocytes from lymph nodes and bone marrow to peripheral blood; it generally peaked by month 2, after which it slowly resolved. Patients generally experienced significant clinical benefit from the improvement in lymphadenopathy, with no negative consequences from the lymphocytosis. The lymphocytosis did limit the response rate, however, to 26%. Thus, Cal-101 is active in the treatment of refractory CLL. Currently, the pan class I PI3K inhibitor BKM120 developed by Novartis is under investigation in phase I and II clinical trials in advanced solid tumor patients<span><a href="#ijc27989-bib-0008" class="bibLink tab-link" id="ijc27989-bib-0008R" data-tab="pane-pcw-references" aria-label="Reference 8 - Blood">8</a>, <a href="#ijc27989-bib-0010" class="bibLink tab-link" id="ijc27989-bib-0010R" data-tab="pane-pcw-references" aria-label="Reference 10 - Nat Rev Drug Discov">10</a></span> (<a href="http://clinicaltrials.gov" class="linkBehavior">clinicaltrials.gov</a>).</p>
         </section>
      <section class="article-section__content" id="ijc27989-sec-0002">
         
         <h2 class="article-section__title section__title section1" id="ijc27989-sec-0002-title"> Material and Methods</h2>
         
         <section class="article-section__sub-content" id="ijc27989-sec-0003">
            
            <h3 class="article-section__sub-title section2" id="ijc27989-sec-0003-title"> Patients</h3>
            
            <p>Sixty-five patients with a diagnosis of B-CLL followed at the Jewish General Hospital of Montreal were enrolled in the study after informed consent. Patients were either clinically untreated (<i>n</i> = 36) or treated with chemotherapy (<i>n</i> = 29) for various time periods (Supporting Information Table 1).</p>
            </section>
         
         <section class="article-section__sub-content" id="ijc27989-sec-0004">
            
            <h3 class="article-section__sub-title section2" id="ijc27989-sec-0004-title"> Cell lines</h3>
            
            <p>The three B-CLL cell lines JVM2, EHEB and MEC2 (DSMZ, Braunschweig, Germany) were maintained in RPMI (Invitrogen, Carlsbad, CA), complemented with 10% fetal bovine serum (FBS). BMS2 stromal cell line were maintained in Dulbecco's modified eagle medium (DMEM) supplemented with 10% FBS.</p>
            </section>
         
         <section class="article-section__sub-content" id="ijc27989-sec-0005">
            
            <h3 class="article-section__sub-title section2" id="ijc27989-sec-0005-title"> Cytotoxicity assay</h3>
            
            <p>Lymphocytes were isolated from the peripheral blood using Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) as described.<span><a href="#ijc27989-bib-0011" class="bibLink tab-link" id="ijc27989-bib-0011R" data-tab="pane-pcw-references" aria-label="Reference 11 - Br J Haematol">11</a></span> The isolated lymphocyte population was 97.85 ± 1.72% malignant B-lymphocytes (expressed as a mean % ± S.D.). The CLL lymphocytes (3 × 10<sup>6</sup> cells/ml) were treated with various concentrations of BKM120 (0.2–20 μM) (Novartis Pharma AG, Basel, Switzerland) or Cal-101 (0.4–50 μM) (LC Laboratories, Woburn, MA). Control samples were incubated with the greatest volume of DMSO. The MTT assay was performed 72 h after treatment as previously described<span><a href="#ijc27989-bib-0012" class="bibLink tab-link" id="ijc27989-bib-0012R" data-tab="pane-pcw-references" aria-label="Reference 12 - J Pharmacol Exp Ther">12</a></span> and the cytotoxic effect of the drug presented as the IC<sub>50</sub> (the drug concentration resulting in 50% of control).</p>
            </section>
         
         <section class="article-section__sub-content" id="ijc27989-sec-0006">
            
            <h3 class="article-section__sub-title section2" id="ijc27989-sec-0006-title"> Western blot analysis</h3>
            
            <p>Cell lysates (50 μg/sample) and protein migration were obtained as described before.<span><a href="#ijc27989-bib-0013" class="bibLink tab-link" id="ijc27989-bib-0013R" data-tab="pane-pcw-references" aria-label="Reference 13 - Leuk Res">13</a></span> The antibodies utilized were: 4E-BP1, 4E-BP1 (Thr37/46), Akt, Akt (Ser473), mTor, p70S6K, p70S6K (Thr389), PTEN, raptor and rictor (Cell signalling Technology, Danvers, MA) and actin, (Santa Cruz Biotechnology, Santa Cruz, CA). The blots were developed using the appropriate HRP-secondary antibodies [anti-mouse (GE Healthcare, Piscataway, NJ), anti-rabbit (KPL, Gaithersburg, MD) or anti-goat (Santa Cruz)] and ECL (GE Healthcare). Protein levels were quantified by densitometry with Scion image software (Scion Corporation, Frederick, MA) and normalized to actin or the total protein expression for the phosphorylated form of the protein.</p>
            </section>
         
         <section class="article-section__sub-content" id="ijc27989-sec-0007">
            
            <h3 class="article-section__sub-title section2" id="ijc27989-sec-0007-title"> Apoptosis assay</h3>
            
            <p>For this assay, 3 × 10<sup>6</sup> cells were treated with the DMSO or BKM120 IC<sub>50</sub> in the presence or absence of stromal cell for 24 hr. The induction of apoptosis was determined using the APC AnnexinV/Dead cell apoptosis kit (Invitrogen).</p>
            </section>
         
         <section class="article-section__sub-content" id="ijc27989-sec-0008">
            
            <h3 class="article-section__sub-title section2" id="ijc27989-sec-0008-title"> Statistical analysis</h3>
            
            <p>The Pearson Product Moment Correlation and <i>t</i>-testing were used for the correlative analysis of predictive biomarkers. The protein expression correlation with BKM120 cytotoxicty with the best <i>p</i> values were utilized to generate Figure <a href="#ijc27989-fig-0001">1</a><i>c</i>. Statistical analyses were performed by Friedman Repeated Measures Analysis of Variance on Ranks followed by Bonferroni t-test with SigmaStat software (Systat Software, San Jose, CA).
</p>
            
            <section class="article-section__inline-figure">
               <figure class="figure" id="ijc27989-fig-0001"><a target="_blank" href="/cms/asset/3c8c4a8b-9cc0-48fc-9b19-1a6b6982dc79/ijc27989-fig-0001-m.jpg"><picture>
                        <source srcset="/cms/asset/3c8c4a8b-9cc0-48fc-9b19-1a6b6982dc79/ijc27989-fig-0001-m.jpg" media="(min-width: 1650px)"></source><img class="figure__image" src="/cms/asset/f6908912-c2f7-4fa0-8f47-d217b17611a2/ijc27989-fig-0001-m.png" data-lg-src="/cms/asset/3c8c4a8b-9cc0-48fc-9b19-1a6b6982dc79/ijc27989-fig-0001-m.jpg" alt="Details are in the caption following the image" loading="lazy"></picture></a><figcaption class="figure__caption">
                     <div class="figure__caption__header"><strong class="figure__title">Figure 1</strong><div class="figure-extra"><a href="#" class="open-figure-link">Open in figure viewer</a><a href="/action/downloadFigures?id=ijc27989-fig-0001&amp;doi=10.1002%2Fijc.27989" class="ppt-figure-link"><i aria-hidden="true" class="icon-Icon_Download"></i><span>PowerPoint</span></a></div>
                     </div>
                     <div class="figure__caption figure__caption-text">
                        <p>The MTT assay was used (a) to determine the cytotoxicity of BKM120 in primary lymphocytes from 65 B-CLL patients and (b) compare the cytotoxic effect of the two PI3K inhibitors BKM120 and Cal-101 in cells from 20 B-CLL patients. (c) The basal protein expression of raptor and p70S6K were analyzed by western blot in 54 B-CLL samples. For each protein, samples were segregated in two groups (the mean expression value for each protein was used as cut-off) and correlated with the BKM120 IC<sub>50</sub>. (d) Akt phosphorylation (Akt S473) was assessed by western blot analysis in three B-CLL cell lines 24 hr after BKM120 treatment. *: p &lt; 0.0001.</p>
                        </div>
                  </figcaption>
               </figure>
            </section>
         </section>
      </section>
      <section class="article-section__content" id="ijc27989-sec-0009">
         
         <h2 class="article-section__title section__title section1" id="ijc27989-sec-0009-title"> Results and Discussion</h2>
         
         <p>In view of the critical role of PI3K in CLL homeostasis, the activity of BKM120 was examined in primary B-CLL lymphocytes and in B-CLL cell lines. The <i>in vitro</i> cytotoxic effect of BKM120 was assessed in 3 B-CLL cell lines and in primary B-lymphocytes isolated from the 65 B-CLL patients enrolled in our study (Supporting Information Table 1) utilizing the MTT assay. The IC<sub>50</sub> (drug concentration resulting in 50% cell death) obtained in the B-CLL cell lines JVM2, EHEB and MEC2 were 0.9 ± 0.1, 0.7 ± 0.1 and 0.7 ± 0.1 μM, respectively. BKM120 was cytotoxic (IC<sub>50</sub> below the maximum concentration (20 μM) of BKM120 used in the MTT assay) in 78% of the primary B-CLL lymphocytes samples tested. There are subsets of patients such as those with 17p (del17) or 11q (del11) deletions, who have a high-risk for poor response to treatment.<span><a href="#ijc27989-bib-0014" class="bibLink tab-link" id="ijc27989-bib-0014R" data-tab="pane-pcw-references" aria-label="Reference 14 - J Clin Oncol">14</a></span> In our study, BKM120 is cytotoxic in patients' samples harboring these deletions (Supporting Information Tables 1–2, Supporting Information Fig. 1). In the phase I clinical study, the maximum plasma concentration (Cmax) of BKM120 obtained after administration of the maximum tolerated dose of the drug was 5 μM.<span><a href="#ijc27989-bib-0015" class="bibLink tab-link" id="ijc27989-bib-0015R" data-tab="pane-pcw-references" aria-label="Reference 15 - J Clin Oncol">15</a></span> Interestingly, 60% of the B-CLL samples tested in our study have an IC<sub>50</sub> below the Cmax. Furthermore, five of six patient samples with del11 or del17 have a clinically achievable IC<sub>50</sub>. These results indicated that BKM120 may be useful as a single agent in CLL therapy (Fig. <a href="#ijc27989-fig-0001">1</a><i>a</i>, Supporting Information Table 2). Previous studies have shown that the PI3Kδ inhibitor CAL-101 is cytotoxic in B-CLL lymphocytes <i>in vitro</i>.<span><a href="#ijc27989-bib-0008" class="bibLink tab-link" id="ijc27989-bib-0008R" data-tab="pane-pcw-references" aria-label="Reference 8 - Blood">8</a>, <a href="#ijc27989-bib-0016" class="bibLink tab-link" id="ijc27989-bib-0016R" data-tab="pane-pcw-references" aria-label="Reference 16 - Blood">16</a></span> We therefore compared, by MTT assay, both PI3K inhibitors for their potency to induce cell death in 20 primary B-CLL cells samples and demonstrated that BKM120 is 3.6 fold more toxic than CAL-101 in malignant B-CLL lymphocytes <i>in vitro</i> (Fig. <a href="#ijc27989-fig-0001">1</a><i>b</i>, Supporting Information Table 2). Furthermore, BKM120 is cytotoxic (IC<sub>50</sub> &lt; 20 μM) in 80% of these 20 samples tested while CAL-101 is only cytotoxic (IC<sub>50</sub> &lt; 50 μM) in 45% of these samples. CLL has a widely variable response to therapy. Thus, we were interested in identifying molecular features that can predict response to BKM120 treatment. We analyzed our samples for somatic mutations in the immunoglobulin variable region (IgVH) genes and CD38 expression profiles as well as the basal expression of proteins involved in the PI3K/Akt pathway. Data Analysis with the Pearson product moment correlation test demonstrated positive correlations between BKM120 cytotoxicity and the basal expression of Akt (<i>r</i> = 0.592, <i>p</i> = 2.468E-06, <i>n</i> = 54), rictor (<i>r</i> = 0.418; <i>p</i> = 1.65E-03; <i>n</i> = 54), raptor (<i>r</i> = 0.463; <i>p</i> = 4.5E-03; <i>n</i> = 54), p70S6K (<i>r</i> = 0.584, <i>p</i> = 3.561E-06, <i>n</i> = 54) and 4E-BP1 (<i>r</i> = 0.371, <i>p</i> = 5.75E-03, <i>n</i> = 54) but not with PTEN, mTor, IgVH or CD38 expression. To further analyze these predictive markers, we used the mean expression value for each protein as a cut-off and, segregated the samples in two groups, samples with low level of basal protein expression (below the cut-off) and high level of basal protein expression (above the cut-off). We then simultaneously examine these different correlative markers together. We demonstrated that all patients with a BKM120 IC<sub>50</sub> ≤ 3 μM expressed low level of raptor and p70S6K (Fig. <a href="#ijc27989-fig-0001">1</a><i>c</i>). Thereby, simultaneous expression of low basal level of these two proteins may be useful to predict response to BKM120.</p>
         
         <p>To determine whether the cytotoxic effect observed in our study was related to BKM120-induced PI3K inhibition, we investigated the phosphorylation status of Akt, a direct downstream target of PI3K in the three cell lines. In all cell lines, including the p53 mutated cell line MEC2, BKM120 inhibits Akt phosphorylation (Akt S473) 24 hr after treatment (Fig. <a href="#ijc27989-fig-0001">1</a><i>d</i>). <i>In vitro</i> studies have identified that stromal cells promoted cell survival and drug resistance of B-CLL lymphocytes by cell–cell interaction and secretion of chemokines.<span><a href="#ijc27989-bib-0017" class="bibLink tab-link" id="ijc27989-bib-0017R" data-tab="pane-pcw-references" aria-label="Reference 17 - Leuk Lymphoma">17</a></span> Furthermore, bone marrow microenvironment modulates the PI3K/Akt pathway and prevents apoptosis of primary CLL lymphocytes.<span><a href="#ijc27989-bib-0018" class="bibLink tab-link" id="ijc27989-bib-0018R" data-tab="pane-pcw-references" aria-label="Reference 18 - Blood">18</a></span> To determine whether stromal cells can protect B-CLL against BKM120 activity, six primary B-CLL samples were tested for AnnexinV/7-AAD staining 24 hr after BKM120 treatment in the presence or absence of the murine stromal cells BMS2. In the absence of BMS2 stromal cell support, BKM120 induced apoptosis in the six primary B-CLL lymphocytes samples tested (mean AnnexinV positive cells: DMSO = 17.2 ± 3.7% <i>vs</i>. BKM = 33.2 ± 5.5%; <i>p</i> &lt; 0.001). As previously described<span><a href="#ijc27989-bib-0017" class="bibLink tab-link" id="ijc27989-bib-0017R" data-tab="pane-pcw-references" aria-label="Reference 17 - Leuk Lymphoma">17</a></span> the stromal cells protected B-CLL lymphocytes from apoptosis (DMSO = 17.2 ± 3.7% <i>vs</i>. BMS2 + DMSO = 5.6 ± 1.1%; <i>p</i> = 0.004) but were not able to protect these malignant lymphocytes against BKM120 (BMS2 + DMSO = 5.6 ± 1.1% <i>vs</i>. BMS2 + BKM120 = 23.6 ± 5.8%; <i>p</i> = 0.005) (Figs. <a href="#ijc27989-fig-0002">2</a><i>a</i> and <a href="#ijc27989-fig-0002">2</a><i>b</i>). The same results were obtained when we assessed the cleavage of caspase-3 (Supporting Information Fig. 2). There is increasing evidence that the major cause of resistance to therapy in CLL patients is a consequence of a small number of leukemic cells that remain. This phenomenon, called minimal residual disease (MRD), is in part a consequence of protection conferred by the stromal microenvironment to the malignant lymphocytes and eradication of MRD by alemtuzumab treatment improved overall and treatment-free survival in CLL patients.<span><a href="#ijc27989-bib-0017" class="bibLink tab-link" id="ijc27989-bib-0017R" data-tab="pane-pcw-references" aria-label="Reference 17 - Leuk Lymphoma">17</a>, <a href="#ijc27989-bib-0019" class="bibLink tab-link" id="ijc27989-bib-0019R" data-tab="pane-pcw-references" aria-label="Reference 19 - J Clin Oncol">19</a></span> Interestingly, our results demonstrated that the stromal cell microenvironment can not protect B-CLL lymphocytes from apoptosis induced by BKM120 treatment.
</p>
         
         <section class="article-section__inline-figure">
            <figure class="figure" id="ijc27989-fig-0002"><a target="_blank" href="/cms/asset/239c9cd1-9311-4e5e-a11c-54a63f1228e8/ijc27989-fig-0002-m.jpg"><picture>
                     <source srcset="/cms/asset/239c9cd1-9311-4e5e-a11c-54a63f1228e8/ijc27989-fig-0002-m.jpg" media="(min-width: 1650px)"></source><img class="figure__image" src="/cms/asset/a1ba2a07-9cbd-47b5-a532-fb2afc74ac04/ijc27989-fig-0002-m.png" data-lg-src="/cms/asset/239c9cd1-9311-4e5e-a11c-54a63f1228e8/ijc27989-fig-0002-m.jpg" alt="Details are in the caption following the image" loading="lazy"></picture></a><figcaption class="figure__caption">
                  <div class="figure__caption__header"><strong class="figure__title">Figure 2</strong><div class="figure-extra"><a href="#" class="open-figure-link">Open in figure viewer</a><a href="/action/downloadFigures?id=ijc27989-fig-0002&amp;doi=10.1002%2Fijc.27989" class="ppt-figure-link"><i aria-hidden="true" class="icon-Icon_Download"></i><span>PowerPoint</span></a></div>
                  </div>
                  <div class="figure__caption figure__caption-text">
                     <p>The potency of BKM120 to induce apoptosis in primary B-CLL lymphocytes in the presence or absence of the BMS2 stromal cells support was analyzed by flow cytometry. (<i>a</i>) Dot plot example for patient CLL33. (<i>b</i>) Scatter plot analysis of the AnnexinV expression in six B-CLL samples. (<i>c</i>) Western blot analysis of the phosphorylation status of 4E-BP1 (Thr37/46) in B-lymphocytes (patients CLL4 and CLL36) 24 hr after BKM120 treatment. (<i>d</i>) Scatter plot of the 4E-BP1 Thr37/46 phosphorylation in 11 CLL samples. (<i>e</i>) Analysis of p70S6K Thr389 in B-lymphocytes (patients CLL34 and CLL39) after BKM120 treatment. (<i>f</i>) Scatter plot of the expression profile of p70S6K 24 hr after BKM treatment in eight B-CLL samples. *: <i>p</i> &lt; 0.0001, **: <i>p</i> &lt; 0.001, ***: <i>p</i> &lt; 0.005.</p>
                     </div>
               </figcaption>
            </figure>
         </section>
         
         <p>Molecular biomarkers such as p70S6K and 4E-BP1 have been used as indicators of PI3K pathway inhibition <i>in vivo</i> and BKM120 inhibits p70S6K phosphorylation in rat fibroblast cell lines <i>in vitro</i>.<span><a href="#ijc27989-bib-0020" class="bibLink tab-link" id="ijc27989-bib-0020R" data-tab="pane-pcw-references" aria-label="Reference 20 - J Clin Oncol">20</a>, <a href="#ijc27989-bib-0021" class="bibLink tab-link" id="ijc27989-bib-0021R" data-tab="pane-pcw-references" aria-label="Reference 21 - Mol Cancer Ther">21</a></span> We demonstrated that the BKM120 IC<sub>50</sub>s correlated with basal p70S6K and 4E-BP1 protein expression in primary B-CLL lymphocytes. We then assessed <i>in vitro</i> the phosphorylation status of these two proteins used as biomarkers <i>in vivo</i>, in 8 (p70S6K T389) and 11 (4E-BP1 T37/46) primary B-CLL samples after treatment with BKM120. Results demonstrated that after 24 hr treatment, BKM120 decreased the phosphorylation status of 4E-BP1 (Figs. <a href="#ijc27989-fig-0002">2</a><i>c</i> and <a href="#ijc27989-fig-0002">2</a><i>d</i>) and p70S6K (Figs. <a href="#ijc27989-fig-0002">2</a><i>e</i> and <a href="#ijc27989-fig-0002">2</a><i>f</i>).</p>
         
         <p>Although many patients are asymptomatic at diagnosis, CLL is a progressive disease and patients eventually require treatment. The main problems during the treatment of patients living with CLL are the side effects of therapies and the resistance developed by malignant cells after these treatments. Thereby, no current standard treatment option results in curative therapy, and all patients eventually die. Taken together, our results demonstrated that the class I PI3K inhibitor BKM120 may be useful as a single agent in CLL patients independently of their IgVh mutational status, CD38 expression or genomic deletions (del11 and del17). Furthermore, a combination of different biomarkers (expression of raptor and p70S6K) may predict the response to BKM120 treatment. Also, BKM120 abolished the protection against apoptosis and drug resistance conferred by the microenvironment to the primary B-CLL lymphocytes <i>in vitro</i>. Our preclinical study demonstrated that BKM120, a molecule with acceptable clinical toxicity,<sup>15</sup> may be useful in the treatment of CLL.</p>
         </section>
      <div class="article-section__content">
         
         <h2 class="article-section__title section__title section1" id="ijc27989-sec-0010-title"> Acknowledgments</h2>
         
         <p>The authors thank the Manitoba CLL tissue bank for the IgVH mutation analysis, Novartis for providing BKM120 and Dr Koren Mann for sharing the BMS2 cells.</p>
         
         <ol></ol>
      </div>
      <section class="article-section article-section__supporting" data-suppl="/doi/suppl/10.1002/ijc.27989?onlyLog=true">
         <div class="accordion article-accordion">
            <h2><a class="accordion__control" role="button" aria-controls="d11856901e207" aria-expanded="false">
                  <div tabindex="0" class="section__title" id="support-information-section"><span>Supporting Information</span><i aria-hidden="true" class="icon-section_arrow_d"></i></div></a></h2>
            <div class="accordion__content" role="region" aria-labelledby="support-information-section" style="display: none;" id="d11856901e207" aria-hidden="false">
               <div class="support-info__table-wrapper article-table-content-wrapper"><p>Additional Supporting Information may be found in the online version of this article.</p>
                  
                  
                  
                  
                  
                  <table class="support-info__table table article-section__table">
                     <thead>
                        <th id="article-filename" scope="col">Filename</th>
                        <th id="article-description" scope="col">Description</th>
                     </thead>
                     <tbody>
                        <tr id="">
                           <td headers="article-filename"><a href="/action/downloadSupplement?doi=10.1002%2Fijc.27989&amp;file=ijc27989-sup-0001-SuppFig1.tif">ijc27989-sup-0001-SuppFig1.tif</a>10.7 MB</td>
                           <td headers="article-description">Supporting Information Figure 1. The MTT assay was used to determine the cytotoxicity of BKM120 in primary lymphocytes from B-CLL patients harboring cytogenetic deletions in chromosome 11 (del11q; n = 5), chromosome 17 (del17p; n = 3), and chromosome 13 (del13q; n = 15). The PI3K inhibitor BKM120 is cytotoxic in B-lymphocytes from patients with del17p or del11q, who have a high-risk for poor response to conventional treatments.</td>
                        </tr>
                        <tr id="">
                           <td headers="article-filename"><a href="/action/downloadSupplement?doi=10.1002%2Fijc.27989&amp;file=ijc27989-sup-0002-SuppFig2.tif">ijc27989-sup-0002-SuppFig2.tif</a>10.7 MB</td>
                           <td headers="article-description">Supporting Information Figure 2. Detection of apoptosis, by flow cytometry analysis of cleaved caspase-3, in primary B-CLL lymphocytes in presence or absence of stromal cell support 24h after BKM120 treatment. A) Dot plot example for patient CLL29. B) Scatter plot analysis of the cleaved caspase-3 in 6 B-CLL samples. **: p &lt; 0.001, ***: p &lt; 0.005.</td>
                        </tr>
                        <tr id="">
                           <td headers="article-filename"><a href="/action/downloadSupplement?doi=10.1002%2Fijc.27989&amp;file=ijc27989-sup-0003-SuppTab1.doc">ijc27989-sup-0003-SuppTab1.doc</a>205 KB</td>
                           <td headers="article-description">Supporting Information Table 1.</td>
                        </tr>
                        <tr id="">
                           <td headers="article-filename"><a href="/action/downloadSupplement?doi=10.1002%2Fijc.27989&amp;file=ijc27989-sup-0004-SuppTab2.doc">ijc27989-sup-0004-SuppTab2.doc</a>77 KB</td>
                           <td headers="article-description">Supporting Information Table 2.</td>
                        </tr>
                        <tr id="">
                           <td headers="article-filename"><a href="/action/downloadSupplement?doi=10.1002%2Fijc.27989&amp;file=ijc27989-sup-0005-SuppTab3.doc">ijc27989-sup-0005-SuppTab3.doc</a>74 KB</td>
                           <td headers="article-description">Supporting Information Table 3.</td>
                        </tr>
                     </tbody>
                  </table>
                  <p class="disclaimer_text">Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.</p>
               </div>
            </div>
         </div>
      </section>
      <section class="article-section article-section__references" id="references-section">
         <div class="accordion article-accordion">
            <h2>
               <div tabindex="0" role="button" class="accordion__control" aria-expanded="false" data-references="/action/ajaxShowEnhancedAbstract?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&ajax=true&doi=10.1002%2Fijc.27989&pbContext=%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27989%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v133.1%3Bjournal%3Ajournal%3A10970215%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215&accordionHeadingWrapper=h2&onlyLog=true"><span class="section__title" id="references-section-1">References</span><i aria-hidden="true" class="icon-section_arrow_d"></i></div>
            </h2>
            <div class="accordion__content" style="display: none;" role="region" aria-labelledby="references-section-1">
               <ul class="rlist separator">
                  
                  
                  <li data-bib-id="ijc27989-bib-0001"><span class="bullet">1</span><span class="author">Klein U</span>, <span class="author">Tu Y</span>, <span class="author">Stolovitzky GA</span>, et al. <span class="articleTitle">Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells</span>. <i>J Exp Med</i> <span class="pubYear">2001</span>; <span class="vol">194</span>: <span class="pageFirst">1625</span>– <span class="pageLast">38</span>.
                     <div class="extra-links" id="e_1_2_6_2_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1084%2Fjem.194.11.1625" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVOkt7c%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=11733577" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000172659500008" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2001&pages=1625-38&journal=J+Exp+Med&author=U+Klein&author=Y+Tu&author=GA+Stolovitzky&title=Gene+expression+profiling+of+B+cell+chronic+lymphocytic+leukemia+reveals+a+homogeneous+phenotype+related+to+memory+B+cells"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0002"><span class="bullet">2</span><span class="author">Burger JA</span>, <span class="author">Tsukada N</span>, <span class="author">Burger M</span>, et al. <span class="articleTitle">Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1</span>. <i>Blood</i> <span class="pubYear">2000</span>; <span class="vol">96</span>: <span class="pageFirst">2655</span>– <span class="pageLast">63</span>.
                     <div class="extra-links" id="e_1_2_6_3_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1182%2Fblood.V96.8.2655" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt12gsLo%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=11023495" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000090003500003" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2000&pages=2655-63&journal=Blood&author=JA+Burger&author=N+Tsukada&author=M+Burger&title=Blood%E2%80%90derived+nurse%E2%80%90like+cells+protect+chronic+lymphocytic+leukemia+B+cells+from+spontaneous+apoptosis+through+stromal+cell%E2%80%90derived+factor%E2%80%901"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0003"><span class="bullet">3</span><span class="author">Gribben JG</span>, <span class="author">O'Brien S</span>. <span class="articleTitle">Update on therapy of chronic lymphocytic leukemia</span>. <i>J Clin Oncol</i> <span class="pubYear">2011</span>; <span class="vol">29</span>: <span class="pageFirst">544</span>– <span class="pageLast">50</span>.
                     <div class="extra-links" id="e_1_2_6_4_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1200%2FJCO.2010.32.3865" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=21220603" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000287082900020" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=544-50&journal=J+Clin+Oncol&author=JG+Gribben&author=S+O%27Brien&title=Update+on+therapy+of+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0004"><span class="bullet">4</span><span class="author">Ponader S</span>, <span class="author">Chen SS</span>, <span class="author">Buggy JJ</span>, et al. <span class="articleTitle">The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo</span>. <i>Blood</i> <span class="pubYear">2012</span>; <span class="vol">119</span>: <span class="pageFirst">1182</span>– <span class="pageLast">9</span>.
                     <div class="extra-links" id="e_1_2_6_5_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1182%2Fblood-2011-10-386417" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFOit7w%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=22180443" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000300400300017" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=1182-9&journal=Blood&author=S+Ponader&author=SS+Chen&author=JJ+Buggy&title=The+Bruton+tyrosine+kinase+inhibitor+PCI%E2%80%9032765+thwarts+chronic+lymphocytic+leukemia+cell+survival+and+tissue+homing+in+vitro+and+in+vivo"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0005"><span class="bullet">5</span><span class="author">de Rooij MF</span>, <span class="author">Kuil A</span>, <span class="author">Geest CR</span>, et al. <span class="articleTitle">The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia</span>. <i>Blood</i> <span class="pubYear">2012</span>; <span class="vol">119</span>: <span class="pageFirst">2590</span>– <span class="pageLast">4</span>.
                     <div class="extra-links" id="e_1_2_6_6_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1182%2Fblood-2011-11-390989" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVOntb8%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=22279054" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000301941700027" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=2590-4&journal=Blood&author=MF+Rooij&author=A+Kuil&author=CR+Geest&title=The+clinically+active+BTK+inhibitor+PCI%E2%80%9032765+targets+B%E2%80%90cell+receptor%E2%80%90+and+chemokine%E2%80%90controlled+adhesion+and+migration+in+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0006"><span class="bullet">6</span><span class="author">Ringshausen I</span>, <span class="author">Schneller F</span>, <span class="author">Bogner C</span>, et al. <span class="articleTitle">Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta</span>. <i>Blood</i> <span class="pubYear">2002</span>; <span class="vol">100</span>: <span class="pageFirst">3741</span>– <span class="pageLast">8</span>.
                     <div class="extra-links" id="e_1_2_6_7_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1182%2Fblood-2002-02-0539" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BD38XoslKlsr4%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=12393602" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000179158500040" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2002&pages=3741-8&journal=Blood&author=I+Ringshausen&author=F+Schneller&author=C+Bogner&title=Constitutively+activated+phosphatidylinositol%E2%80%903+kinase+%28PI%E2%80%903K%29+is+involved+in+the+defect+of+apoptosis+in+B%E2%80%90CLL%3A+association+with+protein+kinase+Cdelta"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0007"><span class="bullet">7</span><span class="author">Cuni S</span>, <span class="author">Perez-Aciego P</span>, <span class="author">Perez-Chacon G</span>, et al. <span class="articleTitle">A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells</span>. <i>Leukemia</i> <span class="pubYear">2004</span>; <span class="vol">18</span>: <span class="pageFirst">1391</span>– <span class="pageLast">400</span>.
                     <div class="extra-links" id="e_1_2_6_8_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1038%2Fsj.leu.2403398" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVehsr4%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=15175625" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000222821500011" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1391-400&journal=Leukemia&author=S+Cuni&author=P+Perez%E2%80%90Aciego&author=G+Perez%E2%80%90Chacon&title=A+sustained+activation+of+PI3K%2FNF%E2%80%90kappaB+pathway+is+critical+for+the+survival+of+chronic+lymphocytic+leukemia+B+cells"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0008"><span class="bullet">8</span><span class="author">Herman SE</span>, <span class="author">Gordon AL</span>, <span class="author">Wagner AJ</span>, et al. <span class="articleTitle">Phosphatidylinositol 3-kinase-delta inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals</span>. <i>Blood</i> <span class="pubYear">2010</span>; <span class="vol">116</span>: <span class="pageFirst">2078</span>– <span class="pageLast">88</span>.
                     <div class="extra-links" id="e_1_2_6_9_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1182%2Fblood-2010-02-271171" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1KisbbF" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=20522708" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000282137300015" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=2078-88&journal=Blood&author=SE+Herman&author=AL+Gordon&author=AJ+Wagner&title=Phosphatidylinositol+3%E2%80%90kinase%E2%80%90delta+inhibitor+CAL%E2%80%90101+shows+promising+preclinical+activity+in+chronic+lymphocytic+leukemia+by+antagonizing+intrinsic+and+extrinsic+cellular+survival+signals"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0009"><span class="bullet">9</span><span class="author">Furman RR</span>, <span class="author">Byrd JC</span>, <span class="author">Brown JR</span>, et al. <span class="articleTitle">CAL-101, An Isoform-Selective Inhibitor of Phosphatidylinositol 3-Kinase P110{delta}, Demonstrates Clinical Activity and Pharmacodynamic Effects In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia</span>. <i>ASH Annual Meeting Abstracts</i> <span class="pubYear">2010</span>; <span class="vol">116</span>:
Abstract  <span class="pageFirst">55</span>.
                     <div class="extra-links" id="e_1_2_6_10_1"><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=55&journal=ASH+Annual+Meeting+Abstracts&author=RR+Furman&author=JC+Byrd&author=JR+Brown&title=CAL%E2%80%90101%2C+An+Isoform%E2%80%90Selective+Inhibitor+of+Phosphatidylinositol+3%E2%80%90Kinase+P110%7Bdelta%7D%2C+Demonstrates+Clinical+Activity+and+Pharmacodynamic+Effects+In+Patients+with+Relapsed+or+Refractory+Chronic+Lymphocytic+Leukemia"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0010"><span class="bullet">10</span><span class="author">Liu P</span>, <span class="author">Cheng H</span>, <span class="author">Roberts TM</span>, et al. <span class="articleTitle">Targeting the phosphoinositide 3-kinase pathway in cancer</span>. <i>Nat Rev Drug Discov</i> <span class="pubYear">2009</span>; <span class="vol">8</span>: <span class="pageFirst">627</span>– <span class="pageLast">44</span>.
                     <div class="extra-links" id="e_1_2_6_11_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1038%2Fnrd2926" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=19644473" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000268517600020" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=627-44&journal=Nat+Rev+Drug+Discov&author=P+Liu&author=H+Cheng&author=TM+Roberts&title=Targeting+the+phosphoinositide+3%E2%80%90kinase+pathway+in+cancer"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0011"><span class="bullet">11</span><span class="author">Amrein L</span>, <span class="author">Panasci L</span>, <span class="author">Gibson SB</span>, et al. <span class="articleTitle">Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro</span>. <i>Br J Haematol</i> <span class="pubYear">2009</span>; <span class="vol">147</span>: <span class="pageFirst">396</span>– <span class="pageLast">8</span>.
                     <div class="extra-links" id="e_1_2_6_12_1"><span><a href="/doi/10.1111/j.1365-2141.2009.07814.x" onclick="newWindow(this.href);return false" class="visitable">Wiley Online Library</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSnsbzM" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=19758122" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000270727900015" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2009&pages=396-8&journal=Br+J+Haematol&author=L+Amrein&author=L+Panasci&author=SB+Gibson&title=Primary+del+17+chronic+lymphocytic+leukaemia+lymphocytes+are+hypersensitive+to+dasatinib+in+vitro"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0012"><span class="bullet">12</span><span class="author">Amrein L</span>, <span class="author">Loignon M</span>, <span class="author">Goulet AC</span>, et al. <span class="articleTitle">Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[<i>h</i>]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase</span>. <i>J Pharmacol Exp Ther</i> <span class="pubYear">2007</span>; <span class="vol">321</span>: <span class="pageFirst">848</span>– <span class="pageLast">55</span>.
                     <div class="extra-links" id="e_1_2_6_13_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1124%2Fjpet.106.118356" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFeru74%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=17351105" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000246452900004" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=848-55&journal=J+Pharmacol+Exp+Ther&author=L+Amrein&author=M+Loignon&author=AC+Goulet&title=Chlorambucil+cytotoxicity+in+malignant+B+lymphocytes+is+synergistically+increased+by+2%E2%80%90%28morpholin%E2%80%904%E2%80%90yl%29%E2%80%90benzo%5Bh%5Dchomen%E2%80%904%E2%80%90one+%28NU7026%29%E2%80%90mediated+inhibition+of+DNA+double%E2%80%90strand+break+repair+via+inhibition+of+DNA%E2%80%90dependent+protein+kinase"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0013"><span class="bullet">13</span><span class="author">Amrein L</span>, <span class="author">Davidson D</span>, <span class="author">Shawi M</span>, et al. <span class="articleTitle">Dual inhibition of the homologous recombinational repair and the nonhomologous end-joining repair pathways in chronic lymphocytic leukemia therapy</span>. <i>Leuk Res</i> <span class="pubYear">2011</span>; <span class="vol">35</span>: <span class="pageFirst">1080</span>– <span class="pageLast">6</span>.
                     <div class="extra-links" id="e_1_2_6_14_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1016%2Fj.leukres.2011.01.004" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVymt70%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=21281966" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000292735300019" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=1080-6&journal=Leuk+Res&author=L+Amrein&author=D+Davidson&author=M+Shawi&title=Dual+inhibition+of+the+homologous+recombinational+repair+and+the+nonhomologous+end%E2%80%90joining+repair+pathways+in+chronic+lymphocytic+leukemia+therapy"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0014"><span class="bullet">14</span><span class="author">Grever MR</span>, <span class="author">Lucas DM</span>, <span class="author">Dewald GW</span>, et al. <span class="articleTitle">Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997</span>. <i>J Clin Oncol</i> <span class="pubYear">2007</span>; <span class="vol">25</span>: <span class="pageFirst">799</span>– <span class="pageLast">804</span>.
                     <div class="extra-links" id="e_1_2_6_15_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1200%2FJCO.2006.08.3089" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvVKmtL4%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=17283363" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000244884600011" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=799-804&journal=J+Clin+Oncol&author=MR+Grever&author=DM+Lucas&author=GW+Dewald&title=Comprehensive+assessment+of+genetic+and+molecular+features+predicting+outcome+in+patients+with+chronic+lymphocytic+leukemia%3A+results+from+the+US+Intergroup+Phase+III+Trial+E2997"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0015"><span class="bullet">15</span><span class="author">Bendell JC</span>, <span class="author">Rodon J</span>, <span class="author">Burris HA</span>, et al. <span class="articleTitle">Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors</span>. <i>J Clin Oncol</i> <span class="pubYear">2012</span>; <span class="vol">30</span>: <span class="pageFirst">282</span>– <span class="pageLast">90</span>.
                     <div class="extra-links" id="e_1_2_6_16_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1200%2FJCO.2011.36.1360" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFCit70%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=22162589" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000302620200016" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=282-90&journal=J+Clin+Oncol&author=JC+Bendell&author=J+Rodon&author=HA+Burris&title=Phase+I%2C+dose%E2%80%90escalation+study+of+BKM120%2C+an+oral+pan%E2%80%90Class+I+PI3K+inhibitor%2C+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0016"><span class="bullet">16</span><span class="author">Hoellenriegel J</span>, <span class="author">Meadows SA</span>, <span class="author">Sivina M</span>, et al. <span class="articleTitle">The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia</span>. <i>Blood</i> <span class="pubYear">2011</span>; <span class="vol">118</span>: <span class="pageFirst">3603</span>– <span class="pageLast">12</span>.
                     <div class="extra-links" id="e_1_2_6_17_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1182%2Fblood-2011-05-352492" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlSqs7bK" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=21803855" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000295359300026" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=3603-12&journal=Blood&author=J+Hoellenriegel&author=SA+Meadows&author=M+Sivina&title=The+phosphoinositide+3%E2%80%B2%E2%80%90kinase+delta+inhibitor%2C+CAL%E2%80%90101%2C+inhibits+B%E2%80%90cell+receptor+signaling+and+chemokine+networks+in+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0017"><span class="bullet">17</span><span class="author">Hayden RE</span>, <span class="author">Pratt G</span>, <span class="author">Roberts C</span>, et al. <span class="articleTitle">Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches</span>. <i>Leuk Lymphoma</i> <span class="pubYear">2012</span>; <span class="vol">53</span>: <span class="pageFirst">537</span>– <span class="pageLast">49</span>.
                     <div class="extra-links" id="e_1_2_6_18_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.3109%2F10428194.2011.610014" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1Orurg%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=21812539" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000302067100006" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=537-49&journal=Leuk+Lymphoma&author=RE+Hayden&author=G+Pratt&author=C+Roberts&title=Treatment+of+chronic+lymphocytic+leukemia+requires+targeting+of+the+protective+lymph+node+environment+with+novel+therapeutic+approaches"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0018"><span class="bullet">18</span><span class="author">Shehata M</span>, <span class="author">Schnabl S</span>, <span class="author">Demirtas D</span>, et al. <span class="articleTitle">Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemia</span>. <i>Blood</i> <span class="pubYear">2010</span>; <span class="vol">116</span>: <span class="pageFirst">2513</span>– <span class="pageLast">21</span>.
                     <div class="extra-links" id="e_1_2_6_19_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1182%2Fblood-2009-10-248054" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyqt7bP" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=20576813" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000282645900019" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=2513-21&journal=Blood&author=M+Shehata&author=S+Schnabl&author=D+Demirtas&title=Reconstitution+of+PTEN+activity+by+CK2+inhibitors+and+interference+with+the+PI3%E2%80%90K%2FAkt+cascade+counteract+the+antiapoptotic+effect+of+human+stromal+cells+in+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0019"><span class="bullet">19</span><span class="author">Moreton P</span>, <span class="author">Kennedy B</span>, <span class="author">Lucas G</span>, et al. <span class="articleTitle">Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival</span>. <i>J Clin Oncol</i> <span class="pubYear">2005</span>; <span class="vol">23</span>: <span class="pageFirst">2971</span>– <span class="pageLast">9</span>.
                     <div class="extra-links" id="e_1_2_6_20_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1200%2FJCO.2005.04.021" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslGhu78%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=15738539" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000228817900015" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=2971-9&journal=J+Clin+Oncol&author=P+Moreton&author=B+Kennedy&author=G+Lucas&title=Eradication+of+minimal+residual+disease+in+B%E2%80%90cell+chronic+lymphocytic+leukemia+after+alemtuzumab+therapy+is+associated+with+prolonged+survival"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0020"><span class="bullet">20</span><span class="author">Clarke PA</span>, <span class="author">Workman P</span>. <span class="articleTitle">Phosphatidylinositide-3-kinase inhibitors: addressing questions of isoform selectivity and pharmacodynamic/predictive biomarkers in early clinical trials</span>. <i>J Clin Oncol</i> <span class="pubYear">2012</span>; <span class="vol">30</span>: <span class="pageFirst">331</span>– <span class="pageLast">3</span>.
                     <div class="extra-links" id="e_1_2_6_21_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1200%2FJCO.2011.38.7167" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFCitLg%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=22162582" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000302620200023" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=331-3&journal=J+Clin+Oncol&author=PA+Clarke&author=P+Workman&title=Phosphatidylinositide%E2%80%903%E2%80%90kinase+inhibitors%3A+addressing+questions+of+isoform+selectivity+and+pharmacodynamic%2Fpredictive+biomarkers+in+early+clinical+trials"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="ijc27989-bib-0021"><span class="bullet">21</span><span class="author">Maira SM</span>, <span class="author">Pecchi S</span>, <span class="author">Huang A</span>, et al. <span class="articleTitle">Identification and characterization of NVP-BKM120, an orally available pan-class I PI3-kinase inhibitor</span>. <i>Mol Cancer Ther</i> <span class="pubYear">2012</span>; <span class="vol">11</span>: <span class="pageFirst">317</span>– <span class="pageLast">28</span>.
                     <div class="extra-links" id="e_1_2_6_22_1"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27989&amp;key=10.1158%2F1535-7163.MCT-11-0474" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27989&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFWltb8%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27989&amp;key=22188813" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27989&amp;key=000300415300007" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=317-28&journal=Mol+Cancer+Ther&author=SM+Maira&author=S+Pecchi&author=A+Huang&title=Identification+and+characterization+of+NVP%E2%80%90BKM120%2C+an+orally+available+pan%E2%80%90class+I+PI3%E2%80%90kinase+inhibitor"target="_blank">Google Scholar</a></span></div>
                  </li>
               </ul>
            </div>
         </div>
      </section>
   </section>
   <div style="display:none">
      <ul class="custom-style-list noteList"></ul>
   </div>
   <div class="pb-dropzone" data-pb-dropzone="citedBy-dropzone"><section id="cited-by" class="article-section article-section__citedBy cited-by"><div class="accordion article-accordion"><h2><div tabindex="0" role="button" aria-controls="cited-by__content" aria-expanded="false" class="accordion__control"><span id="citedby-section" class="section__title">Citing Literature</span><i aria-hidden="true" class="icon-section_arrow_d"></i></div></h2><div id="cited-by__content" data-source="/pb/widgets/citedBy?page=0&amp;widgetId=f6d59956-1f70-4e88-8811-a42ff3d9d1fa&amp;pbContext=%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27989%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v133.1%3Bjournal%3Ajournal%3A10970215%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215" class="accordion__content cited-by__content"><div class="sciteMetricsDropzone"></div></div></div></section></div>
   </article></div></div><div class="col-lg-4 col-md-4 col-sm-4 hidden-xs hidden-sm hidden-md article-row-right"><div class="publication-cover-info clearfix">



        
        <div class="cover-image-wrapper cover-image__image hasDetails"><a href="/toc/10970215/2013/133/1" title="View Volume 133, Issue 1"><img src="/cms/asset/4688d0b2-95bb-45da-9cc0-240f6bae18b7/ijc.v133.1.cover.gif" alt=""/></a></div><div class="extra-info-wrapper cover-image__details"><p class="volume-issue"><a href="/toc/10970215/2013/133/1" title="View Volume 133, Issue 1"><span>Volume</span><span class="val">133</span>, <span>Issue</span><span class="val">1</span></a></p><p>July 2013</p><p class="page-range"><span>Pages</span><span> 247-252</span></p>



        
        
</div>
</div>



        
        <div>



        
        



        <div class="pb-ad">
            <div id="advert-rail-1" class="advert advert-rail">
			<script>

				googletag.cmd.push 		( function () {
					googletag.display 	( 'advert-rail-1' );
				});

			</script>

			<!-- No JavaScript support is a call to an image -->
			<noscript>
				<a href="/action/clickThrough?id=1011&url=https%3A%2F%2Fpubads.g.doubleclick.net%2Fgampad%2Fjump%3Fiu%3D%24googlePublisherCategory%26amp%3Bsz%3D160x600%7C160x320%7C160x160%7C120x600%26amp%3Btile%3D2%26amp%3Bc%3D%24random&loc=%2Fdoi%2F10.1002%2Fijc.27989&pubId=50287102&placeholderId=1014&productId=101018" target="_blank">
					<img src="https://pubads.g.doubleclick.net/gampad/ad?iu=$googlePublisherCategory&amp;sz=160x600|160x320|160x160|120x600&amp;tile=2&amp;c=$random">
				</a>
			</noscript>
		</div>
        </div>
    





        
        



        <div class="pb-ad">
            <aside>
	<div id="advert-rail-2" class="advert advert-rail">
		<script>

			googletag.cmd.push 		( function () {
				googletag.display 	( 'advert-rail-2' );
			});

		</script>

		<!-- No JavaScript support is a call to an image -->
		<noscript>
			<a href="/action/clickThrough?id=1012&url=https%3A%2F%2Fpubads.g.doubleclick.net%2Fgampad%2Fjump%3Fiu%3D%24googlePublisherCategory%26amp%3Bsz%3D160x600%7C160x320%7C160x160%7C120x600%26amp%3Btile%3D2%26amp%3Bc%3D%24random&loc=%2Fdoi%2F10.1002%2Fijc.27989&pubId=50287102&placeholderId=1013&productId=101018" target="_blank">
				<img src="https://pubads.g.doubleclick.net/gampad/ad?iu=$googlePublisherCategory&amp;sz=160x600|160x320|160x160|120x600&amp;tile=2&amp;c=$random">
			</a>
		</noscript>
	</div>
</aside>
        </div>
    

</div>
<div class="tabs__wrapper"><div data-default-tab="related" class="tab tab--slide tab--flex sticko__md tabs--xs dynamic-sticko article__tab  tab--flex  tabs--xs "><ul data-mobile-toggle="slide" role="tablist" class="rlist tab__nav w-slide--list"><li role="presentation" class="tab__nav__item"><a id="pane-pcw-figurescon" href="#pane-pcw-figures" data-slide-clone="self" aria-controls="#pane-pcw-figures" role="tab" data-toggle="tab" data-slide-target="#pane-pcw-figures" class="tab__nav__item__link article-row-right__tabLinks w-slide__btn figures-tab"><i aria-hidden="true" class="icon-multi-figure"></i><h2>Figures</h2></a></li><li role="presentation" class="tab__nav__item"><a id="pane-pcw-referencescon" href="#pane-pcw-references" data-slide-clone="self" aria-controls="#pane-pcw-references" role="tab" data-toggle="tab" data-slide-target="#pane-pcw-references" class="tab__nav__item__link article-row-right__tabLinks w-slide__btn references-tab"><i aria-hidden="true" class="icon-chain"></i><h2>References</h2></a></li><li role="presentation" class="tab__nav__item"><a id="pane-pcw-relatedcon" href="#pane-pcw-related" data-slide-clone="self" aria-controls="#pane-pcw-related" role="tab" data-toggle="tab" data-slide-target="#pane-pcw-related" class="tab__nav__item__link article-row-right__tabLinks w-slide__btn related-tab"><i aria-hidden="true" class="icon-related-circles-extend-button"></i><h2>Related</h2></a></li><li role="presentation" class="tab__nav__item"><a id="pane-pcw-detailscon" href="#pane-pcw-details" data-slide-clone="self" aria-controls="#pane-pcw-details" role="tab" data-toggle="tab" data-slide-target="#pane-pcw-details" class="tab__nav__item__link article-row-right__tabLinks w-slide__btn details-tab"><i aria-hidden="true" class="icon-Icon_Information"></i><h2>Information</h2></a></li></ul><div role="presentation" class="tab__content"><div id="pane-pcw-figures" aria-labelledby="pane-pcw-figurescon" role="tabpanel" class="tab__pane article-row-right__panes empty"></div><div id="pane-pcw-references" aria-labelledby="pane-pcw-referencescon" role="tabpanel" class="tab__pane article-row-right__panes empty"></div><div id="pane-pcw-related" aria-labelledby="pane-pcw-relatedcon" role="tabpanel" class="tab__pane article-row-right__panes"></div><div id="pane-pcw-details" aria-labelledby="pane-pcw-detailscon" role="tabpanel" class="tab__pane article-row-right__panes empty"><div class="contentTab"></div></div><div class="tab__spinner"><div class="tab__spinner--box"><img src="/ux3/releasedAssets/images/spinner.gif" id="spinner" alt=""/></div></div></div></div></div><div class="articleAdvert fixed-element"></div></div></div></article><script>var articleRef = document.querySelector('.article__body:not(.show-references) .article__references');
if (articleRef) { articleRef.style.display = "none"; }

</script><div id="figure-viewer" data-ux3-wrapper="figure-viewer" data-ux3-transformed-by="figureInit" data-ux3-role="parent" role="dialog" class="figure-viewer"><div class="figure-viewer__reg__top clearfix"><div class="figure-viewer__top__right"><a href="#" data-ux3-role="controller" role="button" class="figure-viewer__ctrl__close"><span class="icon-close_thin"><span class="sr-only">Close Figure Viewer</span></span></a></div><div class="figure-viewer__top__left"><a href="#" role="button" class="figure-viewer__ctrl__return is-hidden"><span class="icon-arrow-left"><span class="sr-only">Return to Figure</span></span></a><button title="zoom out" class="figure-viewer__label__zoom icon-zoom-out zoom-out"></button><span tabindex="1" class="zoomSlider js__zoom-slider ui-slider"><input type="range" class="zoom-range"/></span><button title="zoom in" class="figure-viewer__label__zoom icon-zoom-in zoom-in"></button></div></div><div class="figure-viewer__reg__center"><div class="figure-viewer__cent__left"><div class="figure-viewer__hold__fig"><figure class="holder"></figure></div><a href="#" role="button" class="figure-viewer__ctrl__prev"><span class="icon-arrow_l"><span class="sr-only">Previous Figure</span></span></a><a href="#" role="button" class="figure-viewer__ctrl__next"><span class="icon-arrow_r"><span class="sr-only">Next Figure</span></span></a><div class="figure-viewer__hold__list clearfix container"></div></div><div class="figure-viewer__cent__right"><div class="figure-viewer__title"><a title="Open/Close Caption" href="#" class="figure-viewer__ctrl__caption"><span class="icon-doublearrow"></span><span class="figure-viewer__caption__label">Caption</span></a><span class="figure-viewer__title__text"></span></div><div class="figure-viewer__hold__figcap"></div></div></div></div>




        
        <div style="text-align: right!important;"><a style="font-weight: 300!important; font-size: 90%;" href="/doi/pdf/10.1002/ijc.27989">Download PDF</a></div>
</div>
</div></div></div>

        </section>
    
        </div>
    </div><!--end pagefulltext-->
</main>

        </div>
    










        <div data-widget-def="pageFooter" data-widget-id="053994f3-7d80-4bb1-97a4-c67fbc4768cd" class="pageFooter">
        



        
        <footer class="page-footer">
    <div data-pb-dropzone="main">
    



        
        <div class="main-footer">



        
        <style>
    .footer-links {
        text-align: center;
    }
    .footer-links h3 {
        font-weight: 300;
    }
    .footer-links a {
        font-weight: 600;
    }
    @media (min-width: 992px) {
        .footer-links {
            text-align: left;
        }
    }
</style>










        <div data-widget-def="ux3-layout-widget" data-widget-id="2753bec1-a79d-4403-827b-6c788ddd6db3" class="footer-sections">
        



        
            <h2 class="sr-only">
                Additional links
            </h2>
        
        <div class="container"><div class="row"><div class=" col-md-3">



        
        <div class="footer-links mb-3">
  <h3>About Wiley Online Library</h3>
  <ul class="rlist">
    <li><a href="https://www.wiley.com/privacy">Privacy Policy</a></li>
    <li><a href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms of Use</a></li>
    <li><a href="https://onlinelibrary.wiley.com/cookies">Cookies</a></li>
    <li><a href="https://onlinelibrary.wiley.com/accessibility">Accessibility</a></li>
        <li><a href="https://onlinelibrary.wiley.com/publishing-policies">Publishing Policies</a></li>
  </ul>
</div>
</div><div class=" col-md-3">



        
         <div class="footer-links mb-3">
    <h3>Help & Support</h3>
    <ul class="rlist">
      <li><a href="https://hub.wiley.com/community/support/onlinelibrary">Contact Us</a></li>
      <li><a href="https://www.wiley.com/customer-success/wiley-online-library-training-hub">Training and Support</a></li>
    <li><a href="https://onlinelibrary.wiley.com/dmca-notification-policy">DMCA &amp; Reporting Piracy</a></li>
 
    </ul>
  </div>
</div><div class=" col-md-3">



        
         <div class="footer-links mb-3">
    <h3>Opportunities</h3>
    <ul class="rlist">
      <li><a href="https://onlinelibrary.wiley.com/agents">Subscription Agents</a></li>
      <li><a href="https://onlinelibrary.wiley.com/advertisers">Advertisers & Corporate Partners</a></li>
    </ul>
  </div>
</div><div class=" col-md-3">



        
        <div class="footer-links mb-3">
    <h3>Connect with Wiley</h3>
    <ul class="rlist">
      <li><a href="https://www.wiley.com/network">The Wiley Network</a></li>
      <li><a href="https://newsroom.wiley.com/">Wiley Press Room</a></li>
    </ul>
  </div>
</div></div></div>

        </div>
    










        <div data-widget-def="ux3-layout-widget" data-widget-id="86584e25-e4db-4118-9550-9b4f5341a4ac" class="copyright-container">
        



        
        <div class="container"><div class="row"><div class=" col-md-12">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="bfbf6c5d-a650-4662-828f-5275fada9120" class="copyright">
        



        
        <div class="copyright pull-left">Copyright &copy; 1999-2022 <a href="https://www.wiley.com">John Wiley &amp; Sons, Inc</a>. All rights reserved</div>

        </div>
    




        
        <div class="footer-logo pull-right">
        
<a href="https://www.wiley.com" title="Wiley Home Page" aria-label="Wiley"><img alt="Wiley Home Page" src="/pb-assets/tmp-images/footer-logo-wiley-1510029248417.png"></a>

</div>
</div></div></div>

        </div>
    
</div>
    </div>
</footer>

        </div>
    




        
        <!--  -->  <div id="iucr-failure"> <p><i class="icon-notice"></i>The full text of this article hosted at iucr.org is unavailable due to technical difficulties.<a href="#" class="close-iucr-failure"><i class="icon-x"></i></a> </p> </div> 




        
        


















<div class="popup login-popup hidden" role="dialog" tabindex="-1" aria-labelledby="loginPopupHead">



    <div class="content">
        <a href="#" role="button" aria-label="Cancel Login" class="close">
            <i class="icon-tools_close" aria-hidden="true"></i>
        </a>
        <div class="modal__header">
            

<div class="header_logo">
    <img src="/pb-assets/hub-assets/pericles/logo-header-1526603583437.png" alt="">
</div>
        </div>

        <div class="modal__body">
            <div class="ssoLogin">
                
            </div>

            <h2 id="loginPopupHead">Log in to Wiley Online Library</h2>

            































<div class="login-form">
    

    

    
    <form action="/action/doLogin?societyURLCode=" class="bordered" method="post"><input type="hidden" name="id" value="67065c09-4a88-49cd-934c-ac707951d35c" />
        
            <input type="hidden" name="popup" value="true" />
        
        

        
        <input type="hidden" name="loginUri" value="/doi/10.1002/ijc.27989" />
        
            





        <input type="hidden" name="redirectUri" value="/doi/10.1002/ijc.27989" />
    

<input type="hidden" name="loginUri" value="/doi/10.1002/ijc.27989" />
            
        
        
        
                






















    
    
        
    <div class="input-group">
        <div class="label">

            
                    <label for="username">Email or Customer ID</label>
                
        </div>
        
        
                <input id="username" class="login" type="text" name="login" value="" size="15" placeholder="Enter your email"autocorrect="off"spellcheck="false"autocapitalize="off"required="true" />
            
        
                    
                        <div class="actions">
                            
                        </div>
                    
                
    </div>


                
                



















    
    <div class="input-group">
        <div class="label">
            <label for="password">Password</label>
        </div>
        
        
                <input id="password" class="password" type="password" name="password" value="" autocomplete="off" placeholder="Enter your password"autocorrect="off"spellcheck="false"autocapitalize="off"required="true" />
            
        <span class="password-eye-icon icon-eye hidden"></span>
        
                
    </div>

                
                    
                        <div class="actions">
                            
                            <a href="/action/requestResetPassword" class="link show-request-reset-password">
                                Forgot password?
                            </a>
                        </div>
                    
                
            
        
        <div class="loginExtraBeans-dropZone" data-pb-dropzone="loginExtraBeans">
            
        </div>

        
                <div class="align-end">
                    
                    
                            
                            <span class="submit ">
                                <input class="button btn submit primary no-margin-bottom accessSubmit" type="submit" name="submitButton" value="Log In" />
                            </span>
                        
                </div></form>
    <div class="societySpecificInstructions">
        
    </div>
</div>

            
                <div class="login-container clearfix form-btn">
                    <a href="/action/registration" class="linkBtn float-left">
                        
                        NEW USER <span aria-hidden="true">></span>
                    </a>
                    
                        <a href="/action/ssostart?redirectUri=%2Fdoi%2F10.1002%2Fijc.27989" class="linkBtn float-right instituation-login">
                            
                            INSTITUTIONAL LOGIN <span aria-hidden="true">></span>
                        </a>
                    
                </div>
            

        </div>
    </div>
</div>




        
        






<div class="popup change-password-drawer hidden" role="dialog" tabindex="-1" aria-labelledby="changePasswordPopupHead">
    <div class="content">
        <a href="#" class="close cancel" role="button" aria-label="close dialog"><i class="icon-close_thin"></i></a>
        <div class="modal__header">
            

<div class="header_logo">
    <img src="/pb-assets/hub-assets/pericles/logo-header-1526603583437.png" alt="">
</div>

            <h2 id="changePasswordPopupHead">Change Password</h2>
        </div>
        <div class="modal__body">

            <div class="form">

                <form action="/action/changePassword" method="post"><div class="message error"></div>
                    <input type="hidden" name="submit" value="submit" />
                    <div class="input-group">
                        <div class="label">
                            <label for="a589574e-bb98-4c6e-8fed-67365ff05357-old">Old Password</label>
                        </div>
                        <input id="a589574e-bb98-4c6e-8fed-67365ff05357-old" class="old" type="password" name="old" value="" autocomplete="off" />
                        <span class="password-eye-icon icon-eye hidden"></span>
                    </div>
                    <div class="input-group">
                        <div class="label">
                            <label for="a589574e-bb98-4c6e-8fed-67365ff05357-new">New Password</label>
                        </div>
                        <input id="a589574e-bb98-4c6e-8fed-67365ff05357-new" class="pass-hint new" type="password" name="new" value="" autocomplete="off" />
                        <span class="password-eye-icon icon-eye hidden"></span>
                        
                            







    


    


    


<div class="password-strength-indicator" data-min="10" data-max="32" data-strength="3">
    <span class="text too-short">Too Short</span>
    <span class="text weak">Weak</span>
    <span class="text medium">Medium</span>
    <span class="text strong">Strong</span>
    <span class="text very-strong">Very Strong</span>
    <span class="text too-long">Too Long</span>
</div>
                        
                    </div>
                    <input class="button primary submit" type="submit" value="Submit" disabled="disabled" /></form>
                <a href="#" class="fakeFormLastElement"></a>
            </div>
            <div class="success-template hidden">
                <h2>Password Changed Successfully</h2>
                <p>Your password has been changed</p>
            </div>
        </div>
    </div>
</div>





        
        





<div class="popup registration-popup hidden"  role="dialog" tabindex="-1" aria-labelledby="createAccountPopupHead">



    <div class="content">
        <a href="#" class="close" role="button" aria-label="close dialog"><i class="icon-tools_close"></i></a>
        <div class="modal__header">
            <div class="logoDropZone" data-pb-dropzone="logoDropZone">
                
            </div>

            <h2 id="createAccountPopupHead">Create a new account</h2>
        </div>

        <div class="modal__body">
            <form action="/action/registration" class="registration-form" method="post"><input type="hidden" name="redirectUri" value="/doi/10.1002/ijc.27989" />
                <div class="input-group">
                    <div class="label">
                        <label for="4e647394-f751-4441-baa4-df426bca4b6e.email">Email or Customer ID</label>
                    </div>
                    <input id="4e647394-f751-4441-baa4-df426bca4b6e.email" class="email" type="text" name="email" value="" size="15" />
                </div>
                <div class="submit">
                    <input class="button submit primary" type="submit" value="Register" />
                </div></form>
            <div class="center">
                <a href="/action/showLogin" class="show-login">
                    
                    Returning user
                </a>
            </div>
        </div>
    </div>
</div>




        
        



<div class="popup top-drawer request-reset-password-drawer hidden" role="dialog" tabindex="-1" aria-labelledby="resetPasswordPopupHead">
    <div class="content">
        <div class="modal__header">
            <a href="#" class="cancel close" role="button" aria-label="close dialog"><i class="icon-close_thin"></i></a>

            

<div class="header_logo">
    <img src="/pb-assets/hub-assets/pericles/logo-header-1526603583437.png" alt="">
</div>

            <h2 id="resetPasswordPopupHead">Forgot your password?</h2>
            <p class="sub">Enter your email address below. </p>

        </div>

        <div class="modal__body">

            









<div class="error"></div>


<form action="/action/requestResetPassword" class="request-reset-password-form" method="post"><input type="hidden" name="requestResetPassword" value="true" />
    
            <div class="input-group">
                






















    
    
        
    <div class="input-group">
        <div class="label">

            
                    <label for="email">Email or Customer ID</label>
                
        </div>
        
        
                <input id="email" class="email" type="text" name="email" value="" size="15" placeholder="Enter your email"autocorrect="off"spellcheck="false"autocapitalize="off" />
            
        
    </div>

            </div>
        


    
            <div class="password-recaptcha-ajax"></div>
        

    <div class="message error"></div>

    <div class="form-btn">
        <input class="button btn primary submit" type="submit" name="submit" value="RESET PASSWORD" disabled="disabled" />
    </div></form>
            

            <div class="success-template hidden">

                <p>Please check your email for instructions on resetting your password.
                    If you do not receive an email within 10 minutes, your email address may not be registered,
                    and you may need to create a new Wiley Online Library account.</p>

            </div>
        </div>
    </div>
</div>





        
        <div><div class="pb-dropzone" data-pb-dropzone="col-0" title="col-0"></div></div>




        
        




<div class="popup top-drawer request-username-drawer username-popup hidden"  role="dialog" tabindex="-1" aria-labelledby="requestUsernamePopupHead">
    <a href="#" class="close" role="button" aria-label="close dialog"><i class="icon-close_thin"></i></a>
    <div class="content">
        <h2 id="requestUsernamePopupHead">Request Username</h2>
        <div class="form">
            <p>Can't sign in? Forgot your username?</p>
            <p class="sub">Enter your email address below and we will send you your username</p>
            <div class="message error"></div>
            <form action="/action/requestUsername" method="post"><input type="hidden" name="requestUsername" value="requestUsername" />
                <div class="input-group">
                    <div class="label">
                        <label for="ac834f24-aa07-4ad2-9d13-f77c843f21cb.email">Email or Customer ID</label>
                    </div>
                    <input id="ac834f24-aa07-4ad2-9d13-f77c843f21cb.email" class="email" type="text" name="email" value="" size="15" />
                </div>

                <div class="username-recaptcha-ajax">
                </div>

                <input class="button primary submit" type="submit" name="submit" value="Submit" disabled="disabled" />
                <div class="center">
                    <a href="#" class="cancel">Close</a>
                </div></form>
        </div>
        <div class="success-template hidden note">
            <p>If the address matches an existing account you will receive an email with instructions to retrieve your username</p>
        </div>
    </div>
</div>




        
        <!-- Belongs at the bottom of the page -->

<script type="text/javascript">
if(window._satellite) { 
_satellite.pageBottom(); 
}
</script>
        </div>
    </div>








<script src="/products/acropolis/pericles/releasedAssets/js/build.lazyload.bundle-5a18e39b1102801a673f.js"></script><script src="/products/acropolis/pericles/releasedAssets/js/main.bundle-5d90fdc14b265e545d95.js"></script>
<script type="text/javascript" src="/wro/l0m7~product.js"></script>

<script>var _prum=[['id','59e8fecb3847311aab7b23c6'],['mark','firstbyte',(new Date()).getTime()]];(function(){var s=document.getElementsByTagName('script')[0],p=document.createElement('script');p.async='async';p.src='//rum-static.pingdom.net/prum.min.js';s.parentNode.insertBefore(p,s);})();</script>















    <script type="text/javascript">
        $(document).ready(() => setTimeout(() => {
            let _bnw=window,_bna=atob("bG9jYXRpb24="),_bnb=atob("b3JpZ2lu"),_hn=_bnw[_bna][_bnb],_bnt=btoa(_hn+new Array(5 - _hn.length % 4).join(" "));
            $.get("/resource/lodash?t="+_bnt);
        },4000));
    </script>


<script>
    $(document).ready(function () {
        var start = new Date();
        var doi = $("meta[name='dc.identifier']").attr('content');
        $(window).unload(function () {
            var end = new Date();
            $.ajax({
                url: '/action/analytics',
                method: 'post',
                data: {
                    'Duration': end - start,
                    'DOI': doi,
                    'EventType': 'FullTextDuration'
                },
                async: false
            });
        });

        window.onafterprint = function () {
            $.ajax({
                url: '/action/analytics',
                method: 'post',
                data: {
                    'DOI': doi,
                    'EventType': 'FullTextPrint'
                }
            });
        };
    });
</script>
<script type="text/javascript">(function(){window['__CF$cv$params']={r:'6e7ad37048b67e4c',m:'KbDfLm3K4yJsP55NvKGnViqL6CUod8XaPI8fvJFeGGo-1646566925-0-AcBTc+k/KesP7ga4r/SaYuweHwUEeHW6rpDOHiSuevckF67DYfgwLlD4KW6Rz9uRNz5sLkawzKzjMffYhBmQdJkzdhbyZjYzzG0gI7NWvJy3EHMlwl64Tv84cBxjq/xQh8/1tauI/eY0TFAuKcJvU88=',s:[0x5b3a8fb580,0x8586528746],}})();</script><script defer src="https://static.cloudflareinsights.com/beacon.min.js/v652eace1692a40cfa3763df669d7439c1639079717194" integrity="sha512-Gi7xpJR8tSkrpF7aordPZQlW2DLtzUlZcumS8dMQjwDHEnw9I7ZLyiOj/6tZStRBGtGgN6ceN6cMH8z7etPGlw==" data-cf-beacon='{"rayId":"6e7ad37048b67e4c","token":"f3dd54df2ac243bab2129483f57546d1","version":"2021.12.0","si":100}' crossorigin="anonymous"></script>
</body>
</html>
